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ABSTRACT
Programed cell death (PCD) is a fundamental biological process that is as essential 
for the development and tissue homeostasis as cell proliferation, differentiation and 
adaptation. The main mode of PCD - apoptosis - occurs via specifi c pathways, such as 
mitochondrial or death receptor pathway. In the developing nervous system, programed 
death broadly occurs, mainly triggered by the defi ciency of different survival-promoting 
neurotrophic factors, but the respective death pathways are poorly studied. In one of the 
best-characterized models, sympathetic neurons deprived of nerve growth factor (NGF) 
die via the classical mitochondrial apoptotic pathway. The main aim of this study was to 
describe the death programs activated in these and other neuronal populations by using 
neuronal cultures deprived of other neurotrophic factors. 
     First, this study showed that the cultured sympathetic neurons deprived of glial cell 
line-derived neurotrophic factor (GDNF) die via a novel non-classical death pathway, in 
which mitochondria and death receptors are not involved. Indeed, cytochrome c was not 
released into the cytosol, Bax, caspase-9, and caspase-3 were not involved, and Bcl-xL 
overexpression did not prevent the death. This pathway involved activation of mixed 
lineage kinases and c-jun, and crucially requires caspase-2 and -7. Second, it was shown 
that deprivation of neurotrophin-3 (NT-3) from cultured sensory neurons of the dorsal 
root ganglia kills them via a dependence receptor pathway, including cleavage of the NT-
3 receptor TrkC and liberation of a pro-apoptotic dependence domain. Indeed, death of 
NT-3-deprived neurons was blocked by a dominant-negative construct interfering with 
TrkC cleavage. Also, the uncleavable mutant of TrkC, replacing the siRNA-silenced 
endogeneous TrkC, was not able to trigger death upon NT-3 removal. Such a pathway 
was not activated in another subpopulation of sensory neurons deprived of NGF. Third, 
it was shown that cultured midbrain dopaminergic neurons deprived of GDNF or brain-
derived neurotrophic factor (BDNF) kills them by still a different pathway, in which death 
receptors and caspases, but not mitochondria, are activated. Indeed, cytochrome c was 
not released into the cytosol, Bax was not activated, and Bcl-xL did not block the death, 
but caspases were necessary for the death of these neurons. Blocking the components 
of the death receptor pathway - caspase-8, FADD, or Fas - blocked the death, whereas 
activation of Fas accelerated it. The activity of Fas in the dopaminergic neurons could be 
controlled by the apoptosis inhibitory molecule FAIML. For these studies we developed 
a novel assay to study apoptosis in the transfected dopaminergic neurons. Thus, a novel 
death pathway, characteristic for the dopaminergic neurons was described. The study 
suggests death receptors as possible targets for the treatment of Parkinson’s disease, 
which is caused by the degeneration of dopaminergic neurons. 

11.1. Programed cell death
The term “programed cell death” (PCD) 
was introduced by Richard Lockshin 
to denote the death of intersegmental 
muscles during insect metamorphosis 
(Lockshin and Williams, 1964). The 
term was coined to emphasize that the 
death was developmentally programed 
not accidentally. PCD is also often 
called ontogenetic cell death. By current 
understanding, PCD plays a pivotal role 
in the development by sculpting the 
shape of organs and achieving the proper 
cell number by removal of unwanted 
and superfl uous cells, which are initially 
overproduced during development (Vaux 
and Korsmeyer, 1999; Ameisen, 2002). 
It also plays a critical role in pathologic 
processes by eliminating damaged or 
infected cells (Thompson, 1995). Cell 
death has attracted extensive research 
interest, mainly because of the potential 
for understanding oncogenesis and the 
possibility of exploiting the cell death 
program for therapeutic purposes. For 
example, tumor cells bear cell death-
blocking mutations in cellular mechanisms 
that would otherwise have eliminated 
them. On the other hand, intentional 
induction of cell death might provide the 
means for eliminating unwanted cells (e.g. 
tumor cells). 
1.1.1. Programed cell death in the 
development of the nervous system 
PCD controls cell number in multicellular 
organisms and is particularly important 
for the proper development of the nervous 
system. During development of the nervous 
system, neurons are initially produced in 
excess and the surplus is removed during 
the critical PCD periods that coincide 
with target innervation establishment 
(Oppenheim, 1991). Thus, cell death acts 
as a kind of biological sculpturing process 
giving rise to the tissue shape, sharpens 
of the borders of the brain compartments, 
retention of the proper neuronal population, 
and matches to the neuronal number to the 
size of peripheral targets (Oppenheim, 
1991). 
     Massive PCD of postmitotic neurons 
was fi rst detected during the development 
of  interactions between neurons and 
their targets (Oppenheim, 1981). This 
line of studies led to the discovery of 
the fi rst neurotrophic factor, NGF, and 
formulation of the neurotrophic hypothesis 
(Hamburger, 1992; Hamburger, 1993; 
Levi-Montalcini, 1998). In its original 
form, this hypothesis stated that neurons 
compete for a limited amount of survival-
promoting factors provided by the targets 
as means of attaining optimal, quantitative 
innervation of their targets (Barde, 1989). 
More recently, this hypothesis has been 
extended to also include competition for 
support from afferent inputs and other 
cellular partners such as glia (Oppenheim, 
1996). The best characterized neurotrophic 
factors are those of the neurotrophin 
family, especially in the peripheral 
nervous system. Gene knockout studies 
show that specifi c populations of sensory 
or sympathetic neurons are lost in the 
mice lacking a particular neurotrophin or 
neurotrophin receptor. The neurons in the 
central nervous system are less affected 
in these knockout mice (Huang and 
Reichardt, 2001). 
     Several hypotheses have been proposed 
to account for the biological signifi cance 
of neuronal death. Because the operation 
of the nervous system is unique in its 
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2establishment and refi nement of the 
synaptic network and neural circuitry, 
error-correction functions (e.g. deletion 
of harmful cells, negative selection) is 
an attractive hypothesis that provides an 
adaptive rationale for neuronal PCD. In 
fact, some have argued that it may be the 
major role for the PCD of differentiating 
neurons as they form connections (Clarke 
et al., 1998; Finlay and Pallas, 1989; Lamb, 
1988). Also, it has been hypothesized that 
controlling of the number of innervating 
neurons by the target, during the 
ontogenesis (at PCD), is the only chance 
to regulate the neuronal number, as during 
the rest of life the number of almost all 
postmitotic neurons can only diminish 
(Buss et al., 2006). 
Thus, PCD of developing neurons can 
serve a variety of different roles depending 
on the stage of development, neuronal 
subtypes, and species.
1.2. Neurotrophic factors
The classic conceptuation of mechanisms 
underlying the regulation of the neuron 
survival, the neurotrophic factor concept 
(Levi-Montalcini, 1987b; Thoenen et 
al., 1987), was primarily the result of 
embryological studies carried out during 
the 20th century. The target-derived 
neurotrophic factor concept originally 
postulated a neurotrophic molecule that 
was secreted by the innervated tissue 
and taken up by the axon terminal 
(Barde, 1989; Oppenheim, 1991). Such 
neurotrophic molecules were hypothesized 
to be available in a limited amount only 
to those neurons that had successfully 
established synaptic contacts with their 
target cells.  Neurons without the trophic 
support were supposed to die by apoptosis. 
This interdependence of neurogenesis 
and factor support presumably helped 
adjust neuronal numbers to the size of 
the innervation targets. The period the 
number of neurons was established, by 
target-derived neurotrophic factors, was 
called the “programed or ontogenetic 
cell death period” (Oppenheim, 1991). 
The experimental evidence on which the 
neurotrophic factor concept was built 
came mainly from the studies of the fi rst 
discovered and purifi ed neurotrophic factor, 
NGF, and its capacity to promote survival, 
neurite outgrowth, and neurotransmitter 
synthesis of paravertebral sympathetic 
neurons (Levi-Montalcini and Hamburger, 
1951; Levi-Montalcini, 1987b). Several 
families of neurotrophic factors later have 
been found, such as the neurotrophin 
family, GDNF family, members of the 
transforming growth factor beta (TGF-
β) superfamily, and cytokine family. The 
cytokine family consists of numerous 
family members including the ciliary 
neurotrophic factor (CNTF) (Arakawa et 
al., 1990), interleukin 6 (IL-6) (Gadient and 
Otten, 1997), leukemia inhibitory factor 
(LIF) (Kim et al., 2005), cardiotrophin, and 
several other growth factors. They have 
multiple functions on both the peripheral 
and central nervous system. In addition, 
the hepatocyte growth factor, the insulin-
like growth factor (IGF), the fi broblast 
growth factor (FGF) family, and some 
other members of the cytokine family also 
have neutrophic activity (Mitsumoto and 
Tsuzaka, 1999b; Mitsumoto and Tsuzaka, 
1999a). 
Although originally developed for the 
peripheral nervous system, the neurotrophic 
factor concept has also been adapted to 
the central nervous system. Unlike the 
peripheral neurons, which mostly depend 
on a single neurotrophic factor, however, 
the central neurons seem to depend on 
several survival-promoting factors, as 
no massive death of the neurons during 
PCD occurs in the respective knockout 
mice (Oppenheim, 1996).  Extensions and 
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3modifi cations of the classic concept have 
been made over the past few decades. 
Recruitment of trophic support from 
diverse sources, rather than the innervated 
target only, is now increasingly accepted. 
Neurotrophic support may even come 
in an autocrine manner, as with sensory 
neurons (Acheson et al., 1995). Moreover, 
evidence exists showing the requirement 
of multiple neurotrophic factors acting 
simultaneously and/or sequentially on the 
same neuronal population (Davies, 1998).
1.2.1. Neurotrophin family
The neurotrophin family consists of several 
members: NGF, BDNF, and neurotrophin-
3, -4/5, -6, and -7 (NT-3, NT-4/5, NT-6 and 
NT-7) (Hallböök et al., 1991; Gotz et al., 
1994; Nilsson et al., 1998; von Boyen et al., 
2002). NT-6 and NT-7 are only expressed 
in fi sh species. Neurotrophins contain 
a cysteine knot that is formed by three 
disulfi de bonds, and they act exclusively as 
homodimers. The core structure is formed 
by two pairs of intertwined two-strand 
β-sheets, assembled by three disulfi de 
bonds. This core structure is conserved 
in all members of the neurotrophin 
family (Butte et al., 1998; Butte, 2001). 
Neurotrophins are fi rst synthesized as 
precursors (pre-pro-form). The pre-region 
is cleaved in the endoplasmic reticulum 
(ER) during secretion. The pro-form of 
the immature protein is then cleaved either 
in the Golgi or in the secretory granules 
into mature proteins (neurotrophic factors) 
(Seidah et al., 1996). Recently, the pro-
NGF and pro-BDNF were also shown to 
be secreted without being cleaved and 
to have a pro-apoptotic activity of their 
own (Nykjaer et al., 2005). Neurotrophin 
receptors consist of two types of receptors: 
the Trk tyrosine kinase receptor family and 
the neurotrophin receptor p75 (p75NTR). 
The Trk receptor family includes three 
receptors: TrkA, TrkB, and TrkC. Each of 
them binds a set of neurotrophins: TrkA 
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Figure 1. Neurotrophins and their receptors. Trk receptors bind specifi c neurotrophins, whereas 
p75 binds all neurotrophins. Modifi ed from Chao (2003).  
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binds NGF, TrkB binds BDNF and NT-4/5, 
whereas TrkC binds preferentially NT-3 
(Figure 1). P75NTR , belonging to the tumor 
necrosis factor (TNF) receptor family, 
binds all neurotrophins either alone or 
in association with Trk receptors. P75NTR 
enhances the affi nity and specifi city of the 
neurotrophins binding to the Trk receptors 
(Kalb, 2005; Zampieri and Chao, 2006). 
Upon binding of the pro-neurotrophins, 
p75NTR can also activate apoptosis through 
its intracellular domain (Teng et al., 2005; 
Nykjaer et al., 2004).  Thus, these two 
types of neurotrophin receptors can either 
consort or antagonize each other to mediate 
the effects of neurotrophins (Chao, 1992; 
Miller and Kaplan, 2001). P75NTR has also 
been implicated in other processes. For 
example, myelin-based growth inhibitors 
can bind to p75NTR in combination with 
Nogo-R and LINGO-1 as a complex to 
restrict axonal regeneration (Nykjaer et 
al., 2005)          
         
1.2.1.1. Nerve growth factor
NGF is a small secreted protein that 
induces the differentiation and survival of 
particular target neurons. It was the fi rst 
discovered neurotrophic factor by Levi-
Montalcini and Hamburger in 1951. NGF 
is critical for the survival and maintenance 
of sympathetic and sensory neurons (Levi-
Montalcini, 1987b). It, however, has no 
direct survival-promoting effects on motor 
neurons (Henderson et al., 1993). It is 
released from the target cells, binds to and 
activates its high-affi nity receptor (TrkA) 
at the neurite terminals, and is internalized 
by the responsive neuron. NGF binds 
two receptors on the surface of cells 
that respond to this growth factor, TrkA 
and p75NTR. Beside the developmental 
PCD periods, NGF and its receptors are 
produced throughout adult life by many 
different cell types. The dynamically 
regulated expression of NGF and its 
receptors throughout adult life suggests 
multiple functions for NGF signaling. 
The importance of these relationships is 
emerged through experiments disrupting 
the genes for NGF and the receptors. 
Mice defi cient in NGF lose most small 
nociceptive dorsal root ganglion (DRG) 
neurons and sympathetic neurons in the 
peripheral nervous system (Crowley et 
al., 1994). In the central nervous system 
of animals heterozygous for disruption of 
the NGF gene, there is a clear reduction in 
the number of basal forebrain cholinergic 
neurons, atrophy of these cells, and 
reduction in the cholinergic innervation of 
the hippocampus (Chen et al., 1997). Both 
basal forebrain and striatal cholinergic 
neurons, however, are reduced in the 
size and number in TrkA null mutant 
animals (Fagan et al., 1997).  Also, there 
is a marked reduction of both small DRG 
neurons and sympathetic neurons in TrkA 
knockout animals (Smeyne et al., 1994). 
Changes are also detected with p75NTR 
gene disruption in both the peripheral 
and central nervous system (Lee et al., 
1992; Lee et al., 1994; Brennan et al., 
1999; Bamji et al., 1998). NGF plays an 
important role as an intercellular signaling 
molecule throughout development. It 
infl uences a wide range of cell types and 
takes part in numerous functions.
1.2.1.2. Brain-derived neurotrophic 
factor 
BDNF is a member of the neurotrophin 
family of growth factors (Barde et al., 
1982; Leibrock et al., 1989). It acts on 
certain neurons of both the central and 
peripheral nervous system, helping to 
support the survival of existing neurons 
and enhance the growth and differentiation 
of new neurons and synapses (Acheson 
et al., 1995; Huang and Reichardt, 
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2001). In the brain, it is expressed in the 
hippocampus, cortex, and basal forebrain 
areas vital to learning, memory, and 
higher cognitive functions (Yamada and 
Nabeshima, 2003). Two receptors, TrkB 
and p75NTR, are capable of binding on 
the surface and responding to this growth 
factor (Patapoutian and Reichardt, 2001). 
BDNF knockout mice develop a severe 
deletion in the peripheral sensory nervous 
system and lose vestibular function. 
TrkB null mutant animals also exhibit 
similar defi cits. It suggests that BDNF 
is not only required for the survival of 
particular neurons, but also for collateral 
branching and innervation of some targets 
(Jones et al., 1994; Ernfors et al., 1994a; 
Liu and Jaenisch, 2000). Recent studies 
have revealed that proBDNF can induce 
neuronal apoptosis when it binds to p75NTR 
and sortilin receptor complex (Teng et al., 
2005). Pro-neurotrophins are produced in 
the brain in the pathological conditions 
and contribute to the neuronal loss in the 
disease (Volosin et al., 2006).
1.2.1.3. Neurotrophin-3
NT-3 is the third member of the 
neurotrophin family (Maisonpierre et 
al., 1990). NT-3 and its receptor, called 
neurotrophic tyrosine kinase receptor type 
3 (TrkC), are widely expressed, although 
primarily in the nervous system where they 
are presumed to have multiple functions 
during development (Lamballe et al., 
1991; Merlio et al., 1992; Tessarollo et al., 
1997). In primary cultures, NT-3 promotes 
the survival and/or differentiation of cells 
from different populations of the peripheral 
and central nervous system, including 
neural crest cells and oligodendrocyte 
precursors (Maisonpierre et al., 1990; 
Kalcheim et al., 1992; Barres et al., 1994; 
Birren et al., 1993; DiCicco-Bloom et al., 
1993; Averbuch-Heller et al., 1994). In 
vivo studies indicate that NT-3 might have 
a role in the early neurogenesis before 
target innervation. In particular, TrkC is 
expressed by virtually all precursors of the 
sensory neurons before they differentiate 
into subpopulations that express other 
Trks, and NT-3 mutants have early 
embryonic loss of sensory precursors 
(Tessarollo et al., 1993; Farinas et al., 
1994). Blocking the biological activity of 
NT-3 by injection of anti-NT-3 antibodies 
into the animals induces sensory neuron 
loss during gangliogenesis (Gaese et 
al., 1994). Several other studies argue 
that effects in vivo are indirect, because 
they illustrate that Trk proteins are only 
detected in neurons not in neural crest cells 
or neuronal precursors, and the defects in 
NT-3 mutants are due to the death of the 
neurons not the precursors (Farinas et al., 
1998; Huang et al., 1999). Importantly, 
mice defi cient in NT-3 have much greater 
defi ciency in spinal sensory neurons 
(about 70%) than the TrkC knockouts 
(about 30%) (Tessarollo et al., 1994; 
Tessarollo et al., 1997). This discrepancy 
has been explained by the ability of NT-3 
to also activate TrkA and TrkB (Farinas et 
al., 1998). Alternatively, or in addition, the 
sensory neurons could be lost in the NT-3 
knockouts due to death actively triggered 
by de-liganded TrkC (paper II).
 
1.2.2. Glial cell line-derived 
neurotrophic factor family
The GDNF family consists of four 
members: GDNF (Lin et al., 1993), 
neurturin (NRTN) (Kotzbauer et al., 
1996), persephin (PSPN) (Milbrandt et 
al., 1998) and artemin (ARTN) (Baloh 
et al., 1998), which belong to the TGF-β 
superfamily.  These four factors have their 
own preferential receptors, the GDNF 
family receptor alphas (GFRαs). There 
are four GFRαs: GFRα1 (Jing et al., 1996; 
6Treanor et al., 1996), GFRα2 (Baloh et 
al., 1997; Klein et al., 1997), GFRα3 (Jing 
et al., 1997; Worby et al., 1998; Masure 
et al., 1998), and GFRα4 (Thompson et 
al., 1998; Lindahl et al., 2001), plus a 
common receptor tyrosine kinase called 
Ret (rearranged during transfection) 
(Takahashi et al., 1985).  Ret is the 
signaling receptor, whereas GFRs give the 
ligand-specifi city for Ret.
GDNF was originally purifi ed from a 
rat glial cell line as a neurotrophic factor 
to promote the survival of embryonic 
dopaminergic neurons (Lin et al., 1993). 
It is expressed in many tissues and many 
cell types including neurons (Schaar et al., 
1993; Stromberg et al., 1993; Springer et 
al., 1994; Trupp et al., 1995; Suvanto et 
al., 1997). It is broadly expressed in the 
peripheral and central nervous system, 
and has multiple neuronal targets. GDNF 
signals through a receptor complex 
consisting of a ligand-specifi c glycosyl-
phosphatidylinositol-linked binding 
molecule (GFRα1) and the membrane-
spanning Ret (Durbec et al., 1996; Suvanto 
et al., 1997). The binding of GDNF-
GFRα1 to the extracellular domain of 
Ret leads to activation of its intracellular 
tyrosine kinase domain (Airaksinen and 
Saarma, 2002; Bespalov and Saarma, 
2007). Mice defi cient in GDNF die soon 
after birth (Moore et al., 1996). These 
mice completely lack the enteric nervous 
system. GDNF also has a crucial role in 
kidney development and spermatogenesis. 
GDNF-/- mice display complete renal 
agenesis due to a lack of the induction of 
the ureteric bud formation, an early step of 
kidney development (Moore et al., 1996; 
Pichel et al., 1996; Sanchez et al., 1996; 
Meng et al., 2000). The phenotypes of 
GDNF and GFRα1 null mice are strikingly 
similar. For example, about 20-40% of 
spinal and cranial motoneurons are missing 
in GFRα1-/- , similar to that of GDNF 
mutant mice (Cacalano et al., 1998; Garces 
et al., 2000). In the peripheral nervous 
system, no effect on the number of sensory 
neurons of spinal and trigeminal ganglia is 
detected in GFRα1-/- newborns, nor loss of 
SCG neurons. But there are subtle defi cits 
of SCG in GDNF null mice (Airaksinen et 
al., 1999; Cacalano et al., 1998; Enomoto 
et al., 1998). GFRα1 inactivation in vivo 
induces enteric neuron death through a 
non-apopototic path (Uesaka et al., 2007) 
(Table 1). Ret-/- mice, like knockouts from 
GDNF or GFRα1 die soon after birth, the 
phenotypes are also similar. However, 
the migration of SCG precursor cells and 
initial axon growth defect are observed in 
Ret-/-  mice (Enomoto et al., 2001).
GDNF has also received attention 
as a potential therapeutic agent for the 
treatment of certain neurological diseases 
such as Parkinson´s disease.
1.3. GDNF as a neuroprotective trophic 
factor for midbrain dopaminergic 
neurons 
Parkinson’s disease is a degenerative 
disorder of the central nervous system 
(Burke, 2007), characterized by muscle 
rigidity, tremor, slowing of physical 
movement, and in extreme cases loss of 
physical movement. The major symptoms 
of Parkinson’s disease result from the 
loss of dopaminergic neurons in the pars 
compacta region of the substantia nigra 
(SN). Some common causes of Parkinson’s 
disease include genetic alterations, toxins, 
head trauma, cerebral anoxia, and drug-
induced Parkinson’s disease, but in most of 
the cases the actual reason for the disease 
is not known. A number of specifi c genetic 
mutations causing Parkinson’s disease 
have been discovered, but these constitute 
a small minority of all cases (Burke, 2008). 
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Table 1. Phenotypes of mice that lack GDNF or its receptors
Gene knockout Ret GDNF or GFRα1
conditional ablation of
GFRα1
Gross phenotype Lethal at birth Lethal at birth Viable, fertile
Viscerosensory Breathing defect
PG: 40% loss of neurons;
breathing defect ND
Somatosensory DRG: NS
y
endings in whisker
follicle DRG: neuron
number NS, reduced
soma size ND
Sympathetic
SCG: migration and
initial axon growth
defect; subtle deficits
in other ganglia
SCG neurons: NS or
subtle loss ND
Parasympathetic
No SPG or OG;
reduced number and
soma size in SMG and
other ganglia
No SPG or OG; reduced
number and soma size in
SMG and other ganglia ND
Enteric
No neurons in bowel
below stomach
No neurons in bowel
below stomach
the colon; enteric neuron
death induced by GFRα1
inactivation is non-
apoptotic, caspase-3.-7 and
Bax are not involved.
Motor Loss in various nuclei
Moderate loss in various
nuclei ND
Brain SN: NS
learning in adult
GDNF+/- mice ND
Other tissues
No kidneys, moderate
C-cell loss
No kidneys, testis
degeneration in adult
GDNF+/- mice ND
The corresponding references for this table are: Ret knockout (Taraviras et al., 1999; Enomoto et al., 2001); 
GDNF or GFRα1 knockout (Erickson et al., 2001; Oppenheim et al., 2000; Cacalano et al., 1998; Garces 
et al., 2000); conditional ablation of GFRα1 (Uesaka et al., 2007).  DRG: dorsal root ganglion; ND: not 
determined; NS: not signifi cantly different from wild type; OG: otic ganglion; PG: petrosal ganglion; SCG: 
superior cervical ganglion; SMG: submandbular ganglion; SPG: sphenopalatine ganglion; SN: substantia 
nigra; TG: trigeminal ganglion. Modifi ed from Airaksinen and Saarma (2002). 
No cure for Parkinson’s disease exists, and 
all the current treatments retard but do not 
block the progression of the disease (Dauer 
and Przedborski, 2003; Gandhi and Wood, 
2005).  
GDNF and another recently 
discovered factor, conserved dopamine 
neurotrophic factor (CDNF), are the 
most promising neurotrophic factors 
for the treatment of Parkinson’s disease 
(Gill et al., 2003; Lindholm et al., 2007). 
When applied in vivo, GDNF is a potent 
treatment factor in the animal models of the 
Parkinson’s disease. Indeed, treatment with 
GDNF causes signifi cant improvements 
in the critical symptoms of Parkinsonian 
8monkeys (Gash et al., 1996). GDNF or 
CDNF, when delivered to the striatum of 
the mice in the 6-hydroxydopamine (6-
OHDA)-induced Parkinsonian model, 
signifi cantly improved the survival of 
dopaminergic neurons. Importantly, these 
factors also rescued the dopaminergic 
neurons when applied after 6-OHDA 
treatment (Lindholm et al., 2007). GDNF 
has also been applied to the human 
Parkinsonian patients in the clinical 
studies, but again with contradictory 
results. In one study, a signifi cant and 
long-lasting improvement of the symptoms 
followed GDNF treatment, making GDNF 
a very promising treatment factor (Gill et 
al., 2003). Another study, however, failed 
to show a signifi cant improvement in 
the patients and also claimed that GDNF 
treatment has several side effects (Lang 
et al., 2006). Again, the reasons for such 
discrepancy remain to be clarifi ed. For 
example, difference in the methods of 
GDNF delivery into the brain should 
be critically considered as the cause for 
discrepancy.
     Some studies also suggest an essential 
role for GDNF in the ontogenetic death 
of the dopaminergic neurons. Injecting 
GDNF into the striatum postnatally 
suppresses naturally-occurring cell 
death of dopaminergic neurons, whereas 
neutralizing antibodies to GDNF 
augments it (Burke, 2004; Oo et al., 
2003; Oo et al., 2005). Transgenic mice 
that overexpress GDNF exclusively in 
regions of mesencephalic neurons have an 
increased surviving number of substantia 
nigra (SN) dopamine neurons (Burke, 
2006). On the other hand, mice with a 
conditional deletion of the GDNF receptor 
Ret in the dopaminergic system do not 
reveal any defect in the development of 
the dopaminergic system but, instead, 
a degeneration phenotype in the adult 
animals (Jain et al., 2006; Kramer et al., 
2007). The reasons for such discrepancies 
are not known, but may involve the 
differences in the experimental paradigms 
(acute manipulations versus genetic 
germline changes). Also, GDNF could 
exert its trophic effect via receptors other 
than Ret, such as N-CAM (Paratcha et al., 
2003). 
     Despite these different in vivo results, 
GDNF and related factors are promising 
candidates for preventing the degeneration 
of dopaminergic neurons and promoting 
fuctional reinnervation. Understanding 
the GDNF-related death pathways in 
dopaminergic neurons could give new 
ideas of how GDNF treatment may help 
the disease. 
1.4. Classifi cation of cell death: 
apoptosis and necrosis
Cell death has classically been divided 
into two broad categories: apoptosis, in 
which the cell plays an active role, and 
necrosis where the cell dies passively 
due to overwhelming stress. In some 
classifi cations, apoptosis is called type 
I death and necrosis as type III (or 
cytoplasmic) death, whereas an additional 
mode - autophagic death is distinguished 
as type II death (Clarke, 1990). More 
modes of death, however, exist.
     Some forms of nonapoptotic cell death, 
previously labelled necrotic and thus 
assumed to be passive, have turned out 
to be programed, therefore, some have 
referred to these as “necrosis-like” (Vande 
Velde et al., 2000), whereas others prefer 
the term “programed necrosis” (Zong and 
Thompson, 2006). A recently generated 
Nomenclature Committee on Cell Death 
is working to create a more systematic 
classifi cation of the cell death modes 
(Kroemer et al., 2008). 
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by Kerr to describe the phenomenon of a 
form of cell death (Kerr et al., 1972). The 
terms apoptosis and programed cell death 
are often used as synonyms, meaning cell-
intrinsic biochemical programs controlled 
by the doomed cell, i.e. the apoptotic 
pathways. It would be more appropriate, 
however, to use the term PCD in its original 
sense: cell death processes that occur at a 
precise location and time according to a 
developmental program, i.e. ontogenetic 
death (Lockshin and Williams, 1964). 
It is only during the last two decades 
that apoptosis has attracted extensive 
research interests, mainly because of the 
establishment of the molecular pathway of 
apoptosis and the identifi cation of several 
key apoptosis regulators in nematode 
Caenorhabditis elegans and subsequently 
their counterparts in mammals. Apoptosis 
accounts for most physiological cell 
death and is characterized by several 
distinct morphological and biochemical 
features including membrane blebbing, 
cell shrinkage, nuclear fragmentation, 
chromatin condensation, chromosomal 
DNA fragmentation (Williams et al., 
1974) and the formation of apoptotic 
bodies that are engulfed by macrophages 
or neighboring cells (Wyllie et al., 1980; 
Fiers et al., 1999). During the early phase 
of apoptosis, cellular organelles remain 
relatively intact, preventing leakage of 
cellular content into the surrounding 
tissues where it can evoke infl ammatory 
responses (Kerr et al., 1995). Thus, 
the original criteria to defi ne apoptosis 
were purely morphological. Presently, 
additional biochemical criteria are also 
used to defi ne apoptosis. These include 
caspase activation, consumption of 
energy-adenosine diphosphate (ATP), and 
exposure of phosphatidylserine on the cell 
surface. These are not fully suffi cient to 
defi ne apoptosis, however, For example, 
caspases can be also activated in non-
apoptotic vital processes, and some non-
apoptotic programs also require energy. 
Thus, the exact defi nition of apoptosis is 
not yet available. It was recommended that 
apoptosis (and other cell death modalities) 
be defi ned by integrating morphological, 
enzymatic, immunological, etc. criteria 
(Galluzzi et al., 2007). 
Necrosis is usually induced in a 
pathological situation by accidental and 
acute damage to the cell. It begins with 
cell swelling, chromatin digestion, and 
disruption of the plasma membrane and 
organelle membranes. Late necrosis 
is characterized by extensive DNA 
hydrolysis, vacuolation of the endoplasmic 
reticulum, organelle breakdown, and cell 
lysis. The release of intracellular contents 
after plasma membrane rupture is the cause 
of infl ammation and immune response 
in necrosis (Figure 2) (Ravichandran and 
Lorenz, 2007; Chen et al., 2007).
Such binary distinction of apoptosis 
and necrosis, however, is clearly an 
oversimplifi cation. Several non-apoptotic 
death programs exist (see below). Also, 
the necrotic mode of death may include 
several apoptotic features. Many examples 
show the features, to various extents, 
of both death types in the same cell. It 
is believed that at least some aspects of 
necrosis may be programed, although 
perhaps to a lesser extent than in apoptosis. 
Intracellular Ca2+ homeostasis is critical 
for the induction of both necrosis and 
apoptosis (Xu et al., 2001; Schwab et al., 
2002; Leist et al., 1997; Crompton, 1999; 
Proskuryakov et al., 2003). Thus, apoptosis 
and necrosis may occur in response to the 
same death stimuli, and the induced mode 
of death is interchangable under certain 
circumstances.
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1.5. Apoptotic pathways
Based on the mode of cell death induction 
and execution, apoptosis can occur via 
two main pathways: the intrinsic, or 
mitochondrial pathway and the extrinsic, 
or the death receptor pathway. The Bcl-2 
family proteins are the best characterized 
regulators involved in the regulation of 
apoptotic death pathways. Both pathways 
culminate in the activation of caspases, 
which cleave key cellular substrates at 
specifi c aspartate residues, leading to the 
features of apoptosis (Vander Heiden et al., 
2001). Several novel apoptotic pathways 
have also been described, including those 
presented in this study.
1.5.1. Bcl-2 family
The Bcl-2 family is a group of proteins 
that make critical survival/death decisions 
in cells. Proteins of the Bcl-2 family share 
Figure 2. Morphological differences between apoptosis and necrosis. A healthy cell can die 
either apoptotically (right) or necrotically (left). Morphological changes of apoptosis include: I. 
Cell shrinkage, chromatin condensation, and chromosomal DNA fragmentation. II. Fragmentation 
of the cell into the apoptotic bodies. III. Engulfment of the apoptotic bodies. Morphological 
changes of necrosis include: I. Swelling of the cell, partial chromatin digestion. II. Disruption of 
the plasma membrane and organelle membranes. Modifi ed from Kerr (1995). 
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one or more of the four characteristic 
domains of homology entitled the Bcl-2 
homology (BH) domains (named BH1-4), 
which control the ability of these proteins 
to dimerize and function as regulators of 
apoptosis (Gross et al., 1999; Cory and 
Adams, 2002). Functionally, Bcl-2 family 
proteins can be divided into anti-apoptotic 
proteins such as Bcl-2, Bcl-xL, Bcl-w, 
Mcl-1, BOO/DIVA, A1/Bfl -1, and NR-
13, and pro-apoptotic proteins. These can 
be further divided into two subgroups: 
the multidomain proteins Bax, Bak, and 
Bok /Mtd and the BH-3-only subfamily 
members including Bid, Bim, Bad, DP5/
HrK, Bcl-xS, Blk, Bik, BNip3, Nix, Mcl-
1s, Bcl-Gs, Noxa, Puma, and N-Bak. The 
multidomain proteins have three common 
domains (BH1, BH2, BH3), whereas 
BH3-only proteins possess only the BH3 
domain. This is shown in Figure 3. 
The precise mechanisms by which 
the Bcl-2 family proteins co-ordinately 
regulate programed cell death are 
extensively studied, but not fully clear. 
It seems that the activity of Bcl-2 family 
proteins is regulated through formation 
of homo- and heterodimers. Interactions 
between pro- and anti-apoptotic members 
neutralize the activity of each other 
(Korsmeyer, 1999; Adams and Cory, 2001; 
Bouillet and Strasser, 2002; Van Delft 
and Huang, 2006). Anti-apoptotic Bcl-2 
family proteins associate  and integrate 
with the mitochondrial outer membrane, 
endoplasmic reticulum (ER), or nuclear 
Figure 3. A diagrammatic representation of the BCL-2 family proteins. The main functional 
domains are shown: BH1, BH2, BH3, BH4, and the transmembrane (TM) domain. The proteins 
are grouped as pro-survival and pro-apoptosis according to their function. The pro-apoptotic 
members of the BCL-2 family can be subdivided into at least two groups: the proteins containing 
two or three distinct BH domains and the BH3-only proteins. Modifi ed from Cory and Adams 
(2002).
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membrane (Krajewski et al., 1993; Lithgow 
et al., 1994; Hsu et al., 1997; O’Reilly et 
al., 2001; Nutt et al., 2002; Scorrano et al., 
2003). Pro-apoptotic proteins, such as Bax 
or Bak, are debatable for the dysfunction 
of mitochondria or ER and release of 
apoptogenic factors (Lindsten et al., 2000; 
Zong et al., 2001; Wei et al., 2001). BH3-
only proteins are shown to be essential 
initiators of apoptosis (Huang and Strasser, 
2000). Thus, in healthy cells, pro-apoptotic 
proteins are suppressed or sequestered to 
a distinct subcellular compartment and 
kept inactive by diverse posttranslational 
mechanisms (Puthalakath and Strasser, 
2002). In apoptotic cells, however, the 
BH3-only proteins are activated by 
different individual modes.  Subsequently, 
the active BH3-only proteins can bind to 
and inactivate the relevant anti-apoptotic 
proteins, and allow the activation of pro-
apoptotic members, Bax and Bak (Willis 
et al., 2007). 
Bax and Bak are critical pro-apoptotic 
proteins in most cell types (in neurons, 
Bak is replaced by its splice variant N-
Bak (Sun et al., 2001)). In apoptotic cells, 
the conformation of Bax is changed and 
it is translocated from the cytosol to the 
mitochondrial outer membrane where 
it, together with Bak, oligomerizes and 
participates in the formation of pores in 
the mitochondrial outer membrane (Hsu et 
al., 1997; Wolter et al., 1997; Gross et al., 
1998; Goping et al., 1998; Desagher and 
Martinou, 2000; Desagher et al., 1999; 
Korsmeyer et al., 2000; Smaili et al., 2001; 
Nechushtan et al., 2001). It is not clear, 
however, how the conformational change 
of Bax or Bak is induced in apoptotic 
cells and what is the mechanism of Bax 
translocation into mitochondria, although 
in several models, the involvement of tBid 
and Bim have been proposed (Desagher et 
al., 1999; Huang and Strasser, 2000; Eskes 
et al., 2000; Putcha et al., 1999; Whitfi eld 
et al., 2001; Brustovetsky et al., 2003). 
It has been shown that Bax translocation 
and the apoptotic activity is mediated 
by its C-terminal transmembrane region 
(Nechushtan et al., 1999; Schinzel et al., 
2004). 
     The crystal structure of Bax and Bcl-xL 
revealed a similarity to the pore-forming 
domains of bacterial toxins, suggesting a 
pore-forming property of these proteins 
(Muchmore et al., 1996; Petros et al., 
2004). The multi-BH-domain Bcl-2 family 
proteins can indeed generate channels into 
the mitochondrial outer membrane that 
allow the release of macromolecules to 
the cytosol (Martinou and Green, 2001; 
Waterhouse et al., 2002).
     The mechanism by which Bax and/or Bak 
mediate the release of apoptogenic factors 
is also not fully understood (Martinou and 
Green, 2001; Robertson et al., 2003). It 
could be mediated by the channel formation 
and directly activated by Bax and/or Bak 
with (Marzo et al., 1998a; Marzo et al., 
1998b; Marzo et al., 1998c; Narita et al., 
1998; Schendel et al., 1998; Crompton, 
1999; Belzacq et al., 2003; Roucou et al., 
2002) or without the involvement of other 
mitochondrial proteins (Eskes et al., 1998; 
Basanez et al., 1999; Saito et al., 2000; 
Shimizu and Tsujimoto, 2000; Antonsson 
et al., 2000). Another model involves 
the swelling of the mitochondrial matrix 
and the subsequent disruption of the 
mitochondrial outer membrane (Vander 
Heiden et al., 2001), but this model has 
not been confi rmed in most of the studies. 
It is also reported that the interaction of 
activated Bax with mitochondrial lipids, 
in particular cardiolipin, in the absence 
of other proteins is suffi cient to generate 
openings in the membrane and release 
cytochome c (Epand et al., 2002; Ott et al., 
2002; Kuwana et al., 2002). Cytochrome c 
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release is proposed to occur in two steps: 
the detachment from the outer surface of the 
mitochondrial inner membrane, followed 
by permeabilization of the mitochondrial 
outer membrane. Cardiolipin interaction 
with cytochrome c limits the amount of 
cytochrome c release, and reducing the 
cardiolipin level decreases the cytochrome 
c binding to the mitochondrial inner 
membrane (Ott et al., 2007).
      Gene targeting studies have revealed 
that Bcl-xL and Bax are the key anti- or 
pro-apoptotic Bcl-2 family members 
during brain development (Kuan et al., 
2000). Within the anti-apoptotic Bcl-2 
family only the deletion of Bcl-x has been 
reported to result in a clear phenotype 
in neurodevelopment. These mice die 
around embryonic day 13 and had massive 
immature hematopoietic cells and neuronal 
death, whereas Bcl-2 is only crucial for the 
maintenance of some specifi c populations 
of neurons during the early postnatal period 
(Motoyama et al., 1995; Michaelidis et al., 
1996). Bax is a crucial pro-apoptotic Bcl-2 
family member during brain development, 
as disruption of the gene dramatically 
inhibits apoptosis in the nervous system 
and causes resistance to trophic factor 
deprivation (Knudson et al., 1995; Ockel 
et al., 1996b; Deckwerth et al., 1996). Bax/
Bcl-xL double knockout mice show that 
the lack of Bax can neutralize the neuronal 
loss caused by Bcl-xL defi ciency (Shindler 
et al., 1997). While Bak knockout mice 
develop normally, most Bax/Bak double 
knockout mice die during embryogenesis, 
indicating that Bax and Bak have 
overlapping roles in the regulation of 
apoptosis during development (Lindsten 
et al., 2000). Bim and DP5 also play an 
important role in neuronal cell death in 
vivo (Strasser et al., 2000; Imaizumi et al., 
2004; Coultas et al., 2007). 
1.5.2. Caspase family
Despite the diversity of death stimuli 
and immediate signal transduction 
pathways, the execution of apoptosis 
is always implemented by a family 
of cysteine proteases, called caspases 
(cysteinyl aspartate-specifi c proteinases) 
(Thornberry et al., 1997a; Honglin and 
Junying, 1999; Earnshaw et al., 1999; 
Denault and Salvesen, 2002). Caspases 
cleave cellular substrate after specifi c 
aspartate residues, while three amino acid 
residues upstream of the aspartate residue 
determine the substrate specifi city of 
individual caspases (Cerretti et al., 1992; 
Lazebnik et al., 1994; Takahashi et al., 
1996; Thornberry et al., 1997a; Sakahira 
et al., 1998). Recent studies demonstrate 
that current knowledge of preferred sites 
for individual caspases is not fully correct 
and the issue requires further studies (Van 
Damme et al., 2005; McStay et al., 2007; 
Timmer and Salvesen, 2006). Activation of 
caspases above a certain threshold presents 
a point of no return during apoptosis. The 
morphological and biochemical features of 
apoptosis are a collective consequence of 
cellular degradation by caspases. Caspases 
can be divided into infl ammatory caspases 
(caspase-1, -4, -5, and -11) (Yuan et al., 
1993; Wang et al., 1998) that are essential 
for the maturation of cytokines, and 
apoptotic caspases (caspase-2, -3, -6, -7, 
-8, -9, -10, and -12). Apoptotic caspases 
can again be divided into initiator caspases 
(caspase-2, -8, -9, -10, and -12) that have 
a long prodomain (Slee et al., 1999) and 
effector caspases (caspase-3, -6, and -7) 
that have a short prodomain. The long 
prodomains of caspase-8 and caspase-10 
have two tandem repeats of death effect 
domains (DEDs), which mediate their 
homophilic interactions with the DED-
containing adaptor proteins like FADD 
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(Vincenz and Dixit, 1997). The prodomain 
of caspase-9 and caspase-2 contain caspase 
recruitment domains (CARDs) that 
mediate the interaction of these caspases 
with other CARD-containing molecules 
such as Apaf-1 (Zou et al., 1997; Li et al., 
1997; Hofmann et al., 1997) (Figure 4).
Caspases are generated as inactive 
zymogens or pro-caspases. Activation of 
a caspase involves two proteolytic steps: 
fi rst cleavage at the site between the small 
and large subunit and then cleavage at 
the site between the prodomain and large 
subunit. Two large and two small subunits 
form a heterotetramer representing an 
active caspase (Figure 5.2). Therefore, 
the prodomain of caspase functions as an 
interaction domain and inhibitory domain. 
In response to apoptotic stimulus, initiator 
caspases become activated by a proximity-
induced dimerization without cleavage. 
Cleavage is neither required nor suffi cient 
for activation initiator caspases but only 
enhances their activity (Logue and Martin, 
2008; Riedl and Salvesen, 2007; Boatright 
et al., 2003; Bao and Shi, 2007).
Figure 4. Classifi cation of caspases. (a) Classifi cation of the caspase family based on the 
functions. (b) General structure of caspases and classifi cation based on the prodomain length. 
(c) Caspase substrate specifi cities. Data are based on (Thornberry et al., 1997b). Preferred amino 
acids in P4-P1 positions are shown. Based on the size of the S4 subsite and P4 residue, caspases 
can be divided into three subfamilies. Modifi ed from Degterev (2003).
Review of the Literature
15
In the death receptor pathway, pro-
caspase-8 or -10 is recruited to the death-
inducing signaling complex (DISC) via 
the DED domain, and activated by induced 
proximity (Figure 5). In the mitochondrial 
pathway, release of cytochrome c from 
the mitochondria to the cytosol leads to 
assembly of the apoptosome that recruits 
pro-caspase-9 via the CARD domain 
(Figure 5). Similarly to pro-caspase-
8, pro-caspase-9 can also be activated 
without processing because of its unusally 
long linker between its large and small 
subunits. Most of the active caspase-9 
remains complexed with apoptotic protease 
activating factor-1 (Apaf-1) (Stennicke 
and Salvesen, 1999; Acehan et al., 2002). 
The effector caspases such as caspase-3, -
6, and -7 are activated through proteolysis 
by upstream initiator caspases (Muzio 
et al., 1998; Salvesen and Dixit, 1999; 
Strasser et al., 2000). Collective action 
of the executioner caspases fi nally brings 
about the apoptotic death of the cell. 
Caspase-2 is a CARD-containing 
caspase with effector-caspase substrate 
cleavage preference, suggesting that it may 
function as both an initiator and effector 
caspase. Accumulating evidence indicates 
that caspase-2 could be activated as an 
initiator caspase upstream or independent 
of mitochondria (Lassus et al., 2002; 
Robertson et al., 2002; Guo et al., 2002; 
Baliga and Kumar, 2003; Blaschke et 
al., 1996; Read et al., 2002). Caspase-
2 is localized in the Golgi complex and 
its cleavage is dependent on Apaf-1 and 
caspase-9 (Mancini et al., 2000). It is 
also localized in the nuclei and triggers 
cytochrome c release from the nuclei in 
turn to induce apoptosis (Parone et al., 
2002). How caspase-2 becomes activated 
is still poorly known. Recently several 
studies have shown that during stress-
induced apoptosis, activation of caspase-2 
occurs in a complex called PIDDosome, 
consisting of a death domain-containing 
protein PIDD, RAIDD, and caspase-2 
(Tinel and Tschopp, 2004; Park et al., 
2007) (Figure 5.1).  Apoptosis induced by 
overexpression of RAIDD in sympathetic 
neurons is dependent on caspase-2 (Jabado 
et al., 2004). Delayed death of CA1 neurons 
after transient ischemia is mediated by a 
complex that includes PIDD, RAIDD, 
and caspase-2 (Niizuma et al., 2008). We 
recently described a novel death pathway in 
the GDNF-deprived sympathetic neurons 
that is most probably initiated by activation 
of caspase-2 without apoptosome or DISC 
(paper I).  Further elucidation of caspase-
2 activation would probably shed light 
on whether the PIDDosome formation is 
involved after GDNF deprivation.        
Caspases are highly specifi c 
endoproteinases, which generate discrete 
fragments that are not further processed. 
Some proteins are activated by cleavage, 
whereas others are inactivated. For 
example, caspases themselves are the 
substrates of activated caspases. A caspase 
substrate concept has been proposed based 
on a relatively few proteins that match the 
consensus substrate specifi city of caspase 
(Timmer and Salvesen, 2006). More than 
280 caspase substrates have been identifi ed 
and several of them act as transducers and 
amplifi ers that determine the apoptosis 
(Fischer et al., 2003).
Targeted gene disruption of individual 
caspases has revealed that they perform 
essential functions in development, 
immune regulation, proliferation, and 
apoptosis (Puthalakath and Strasser, 2002; 
Wang and Lenardo, 2000). But for a given 
death signal, a specifi c caspase may be 
essential in one cell type and dispensable 
in another. Female mice defi cient in 
caspase-2 had overaccumulation of 
germ cells, indicating that caspase-2 was 
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Figure 5. 1. Protein complexes responsible for the activation of initiator caspases. The 
activation of caspase-9, caspase-8, and caspase-2 in mammalian cells is mediated by the 
apoptosome (A), the DISC (B), and the PIDDosome (C). The apoptosome is composed of seven 
molecules of Apaf-1 bound to cytochrome c in the presence of ATP/dATP. DISC is assembled 
following the binding of death ligand to its receptor and contains FADD and caspase-8 (or –10). 
The PIDDosome contains at least three components, PIDD, RAIDD, and caspase-2. Modifi ed 
from Ho and Hawkins (2005). 2. Cartoon representation of the two molecular mechanisms of pro-
caspase activation. (a) Activation of initiator caspases. The zymogens of initiator caspases exist 
as latent monomers. These monomers are activated by dimerization, which allows translocation 
of the activation loop (depicted as a red ‘sausage’) into the accepting pocket of the neighboring 
dimer. The active site is represented by an orange patch. (b) Activation of executioner caspases. 
The zymogens of executioner caspases exist as preformed dimers. Their zymogen latency is 
maintained by steric hindrances imposed by the interdomain linker (depicted as a yellow ‘banana’). 
Cleavage of this linker permits translocation of the activation loop, facilitating formation of the 
active site. Adapted from Boatright and Salvesen (2003).     
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critically required for apoptosis of oocytes. 
These mice also had a decreased number 
of facial motor neurons (Bergeron and 
Yuan, 1998). Sympathetic neurons from 
caspase-2 defi cient mice showed increased 
sensitivity to NGF deprivation induced 
apoptosis, but remained resistant to 
apoptosis induced by β-amyloid treatment. 
The effects of caspase-2 deletion on 
sympathetic neurons were attributed to the 
compensatory overexpression of caspase-
9 and Smac/DIABLO (Troy et al., 2001). 
Apoptosis in the neural progenitor cells 
of the forebrain requires caspase-9 and -
3 or Apaf-1. Mice defi cient in caspase-3 
(Kuida et al., 1996), caspase-9 (Hakem et 
al., 1998) or Apaf-1 (Yoshida et al., 1998) 
show developmental defects in the central 
nervous system and exhibit prominent 
forebrain malformation (Zaidi et al., 2001; 
Roth and D’Sa, 2001; D’Sa-Eipper et al., 
2001). Caspase-8 knockout mice died 
around embryonic day 12.5 due to the 
defect in heart development. The number 
of hematopoietic precursors is dramatically 
reduced due to a reduced proliferative 
capacity. Moreover, fi broblasts from 
caspase-8 defi cient mice are completely 
resistant to death receptor mediated 
apoptosis. Thus, besides its critical role 
in apopotosis, caspase-8 is also essential 
for the growth and differentiation of heart 
muscle and hematopoietic progenitors 
cells (Varfolomeev et al., 1998).      
1.5.3. Intrinsic or mitochondrial 
apoptotic pathway
Death signals, such as cellular stress 
or deprivation of survival promoting 
factors, trigger apoptosis by releasing 
of the mitochondrial death machinery 
(Desagher and Martinou, 2000; Ferri 
and Kroemer, 2001; Kroemer and Reed, 
2000). Mitochondria play a central role in 
this pathway by releasing of mitochondrial 
proteins, such as cytochrome c (Liu et al., 
1996); apoptosis inducing factor (AIF) 
(Susin et al., 1999), and Smac/DIABLO 
(Second mitochondria-derived activator of 
caspase/Direct IAP binding protein) (Du et 
al., 2000; Verhagen et al., 2000), normally 
residing in the intermembrane space  into 
the cytosol. The Bcl-2 family of proteins 
critically regulate the mitochondrial 
apoptotic function. Following death 
stimulus, pro-apoptotic Bcl-2 family 
proteins become activated, inducing 
mitochondrial membrane permeabilization 
and releasing cytochrome c and other 
apoptotic factors into the cytosol. Once 
released, cytochrome c binds to Apaf-
1 in the presence of ATP/dATP and 
induces the assembly of an apoptosome. 
Pro-caspase-9 binds to the apoptosome 
and is activated there by dimerization to 
the induced proximity mode (Pop et al., 
2006). Activated caspase-9 proteolytically 
activates effector caspases such as caspase-
3, -6, and -7, which cleave the cellular 
substrates leading to cell death (Figure 6) 
(Liu et al., 1996; Li et al., 1997; Zou et 
al., 1997; Slee et al., 1999). On the other 
hand, the inhibitor of the apoptosis protein 
(IAP) family also critically regulates the 
programed cell death by binding and 
inhibiting caspases (Takahashi et al., 
1998; Sun et al., 1999; Sun et al., 2000; 
Deveraux and Reed, 1999; Salvesen and 
Duckett, 2002; Fesik, 2000). To ensure 
the full activation of the caspases both 
Smac/DIABLO and Omi/HtrA antagonize 
the activity of IAPs (Slee et al., 1999; 
Verhagen et al., 2000; Wu et al., 2000; Liu 
et al., 2000; Chai et al., 2000; Verhagen et 
al., 2002; Verhagen and Vaux, 2002). 
                  
1.5.4. Extrinsic or death receptor 
apoptotic pathway
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The extrinsic pathway triggers apoptosis 
through the engagement of the cell 
surface death receptors by their ligand. 
This activates the caspase cascade, which 
carries out numerous proteolytic events 
that mediate the apoptotic cell death 
program.
1.5.4.1 Death receptors
Death receptors form a subgroup in the 
large TNF receptor superfamily and are cell 
surface receptors that transmit apoptotic 
signals initiated by specifi c death ligands 
(Smith et al., 1994; Ameyar-Zazoua 
et al., 2002). They contain the death 
domain, which enables death receptors to 
mediate the extrinsic cell death pathway 
(Tartaglia et al., 1993; Nagata, 1997). 
The best characterized death receptors 
are Fas (CD95/Apo1) (Itoh et al., 1991) 
and TNFR1 (CD120a/p55) (Tartaglia 
and Goeddel, 1992). Also TRAIL and its 
receptors TRAILR1 and TRAILR2 have 
Figure 6. Mitochondrial death pathway:  Following apoptotic stimuli, including cellular stress 
or deprivation of survival promoting factors, Bax is translocated to the mitochondria, causing 
cytochrome c and other mitochondrial proteins such as AIF and DIABLO to be released into the 
cytosol as a result of mitochondrial outer membrane permeabilization. This is followed by the 
formation of the apoptosome complex and caspase-9 activation. Modifi ed from Green and Evan 
(2002). 
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attracted considerable attention (Johnstone 
et al., 2008). Death receptor ligands 
are also transmembrane proteins of the 
tumor necrosis factor superfamily and can 
activate the receptors mainly through cell-
cell contacts.
Fas is expressed broadly in various 
tissues, particularly thymocytes and 
activated T cells (Debatin et al., 1993; 
Katsikis et al., 1995). Ligation of Fas by 
FasL or cross-linking of Fas by agonistic 
antibodies induces apoptosis of Fas-
bearing cells (Itoh et al., 1991; Trauth 
et al., 1989). Several studies show that 
cells expressing IAP or p35 are resistant 
to death induced by Fas. In addition, 
caspase inhibitors can block Fas-induced 
apoptosis. This indicates that caspases 
are mediators of Fas-induced apoptosis 
(Beidler et al., 1995; Enari et al., 1995; 
Enari et al., 1996). The mechanism of 
caspase activation by Fas/DISC has been 
extensively studied. Fas ligation leads to 
the formation of its clusters. An adaptor 
protein FADD, which also contains a 
death domain (DD), binds to the clustered 
receptor through its own death domain 
(Boldin et al., 1996; Chinnaiyan and Dixit, 
1996). FADD also has a death effector 
domain (DED) at its N-terminus that can 
bind to pro-caspase-8. Formation of the 
DISC induces the oligomerization and 
subsequently self-cleavage of pro-caspase-
8 (Martin et al., 1998; Muzio et al., 1998; 
Yang et al., 1998). Caspase-8 can then 
activate a downstream effector caspase. 
Ligated TNFR1 also assembles DISC 
with a different composition, including 
adapter TNFR-associated death-domain 
(TRADD), FADD, and pro-caspase-8 
(Micheau and Tschopp, 2003). Negative 
regulators of death receptor signaling such 
as vFLIPs and cFLIP also exist (Thome 
et al., 1997; Shu et al., 1997; Hu et al., 
1997; Srinivasula et al., 1997). Several 
Fas regulatory molecules are expressed in 
the nervous system such as, lifeguard and 
PEA15 (Boldin et al., 1995; Somia et al., 
1999; Fernandez et al., 2007). Recently 
an apoptosis inhibitory molecule FAIML 
(long isoform of Fas apoptosis inhibitory 
molecule) was described as interacting 
with and blocking the apoptotic activity 
of Fas, specifi cally in neurons (Segura 
et al., 2007). Studies with Fas-defi cient 
mice reveal that Fas has physiological and 
pathological roles in the immune system 
(Cohen and Eisenberg, 1991).
Death receptors such as TNFR1, as 
well as Fas, can trigger both survival and 
apoptotic pathways. At the cell surface, 
the ligated death receptors assemble 
a complex (complex I) that includes 
TRADD, the kinase RIP1, and TRAF2, 
but not pro-caspase-8, which can activate 
survival-promoting NF-kB pathway. It is 
only in the cytosol, after the receptors are 
endocytosed, that DISC (complex II) is 
collected, leading to caspase-8 activation 
and cell death (Micheau and Tschopp, 
2003; Schutze et al., 2008). Thus, the 
death receptors can trigger different, even 
opposite signals that are regulated by 
receptor endocytosis. 
1.5.4.2. Death receptor apoptotic 
pathway
 
The “extrinsic” cell death signals, such 
as those mediated by death receptors of 
the TNF receptor superfamily, activate 
the caspase cascade more directly. This 
direct cell death occurs through ligation 
and activation of the plasma membrane 
death receptors on target cells and is 
very important for the immune system 
(Krammer, 2000). The best characterized 
death receptor Fas contains an extracellular 
cysteine-rich domain and an intracellular 
death domain essential for interacting 
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and recruiting adaptor molecules. Death 
ligands belong to the TNF superfamily and 
signal by inducing trimerization of their 
cognate death recptors. This trimerization 
usually leads to apoptosis (Schulze-
Osthoff et al., 1998; Ashkenazi and Dixit, 
1998; Nagata, 1997). Ligand binding to the 
death receptor, for example Fas or TRAIL/
apo-2L, causes the aggregation of the 
death receptors on the plasma membrane 
and recruitment of a cytoplasmic adaptor 
FADD (Vincenz and Dixit, 1997), forming 
a death-inducing signaling complex 
(DISC) (Figure 7) (Kischkel et al., 1995; 
Chinnaiyan et al., 1995; Medema et al., 
1997; Papoff et al., 1999; Chan et al., 
2000; Walczak and Sprick, 2001). Pro-
caspase-8 or -10 is recruited to DISC by 
binding to Fas-associated protein with 
a death domain (FADD) via their death 
effector domains (DEDs) and activated 
by an induced-proximity manner (Muzio 
et al., 1998; Fernandes-Alnemri et al., 
1996; Vincenz and Dixit, 1997; Wang et 
al., 2001). Activated caspase-8 or -10 can 
in turn initiate the activation of the caspase 
cascade by direct cleavage of effector 
caspases such as caspase-3, -6, and -7 (type 
1 cells). TNFR-1 also activates caspase-
8 and -10 through FADD, but TNFR-1 
Figure 7. Death receptor pathway. The extrinsic pathway is triggered by the binding of death 
ligands to their receptors on the cell surface. This results in the recruitment of the adaptor 
proteins, such as FADD, and formation of the death inducing signaling complex (DISC) at their 
intracellular regions. The DISC promotes the activation of initiator caspases, most prominently 
caspase-8, that in turn cleave and activate the effector caspases. DD: death domain. Modifi ed 
from Green and Evan (2002).
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requires TRADD (TNFR1 associated 
death domain protein) to act as an adaptor 
between the receptor and FADD (Hsu et 
al., 1995). In some cases the activation of 
caspase-8 is very slow, thus the death signal 
needs to be amplifi ed by the mitochondrial 
pathway (type 2 cells). In these cells, 
caspase-8 cleaves p22 Bid, a BH3-only 
Bcl-2 family member protein, into P15 
tBid, which then binds to and activates 
Bax and/or Bak, the pro-apoptotic Bcl-2 
family proteins, inducing mitochondrial 
permeabilization and subsequent cell 
death (Scaffi di et al., 1998; Li et al., 1998; 
Luo et al., 1998; Scaffi di et al., 1999). 
Thus, in type 2 cells, a crosstalk between 
the intrinsic and extrinsic pathways can 
occur.
1.6. Non-apoptotic programed cell 
death pathways
Apoptosis has been studied extensively. 
Although programed cell death has often 
been equated with apoptosis, it has become 
more and more clear that several non-
apoptotic forms of programed cell death 
occur (Galluzzi et al., 2007; Bredesen, 
2007).
1.6.1. Autophagic cell death
Autophagy was fi rst described in the 1960s 
as a process whereby a cell digests its own 
components. Autophagy can be broadly 
separated into three types: macroautophagy, 
microautophagy, and chaperone-mediated 
autophagy. Macroautophagy involves 
the formation of a de novo-formed 
membrane sealing on itself to engulf 
cytosolic components (proteins and/or 
whole organelles), which are degraded 
after fusion with the lysosome, whereas 
microautophagy is the direct invagination 
of materials into the lysosome. A variety 
of autophagic processes exist, all of which 
involve the degradation of intracellular 
components via the lysosome.
Autophagy is best characterized 
in yeast cells as a process facilitating 
cell survival in hard conditions. During 
nutrient starvation, the increased levels 
of autophagy lead to the breakdown of 
non-vital components and the release of 
nutrients, ensuring that vital processes can 
continue (Yorimitsu and Klionsky, 2005). 
Mutant yeast cells that have a reduced 
autophagic capability rapidly perish in 
nutrition-defi cient conditions. Autophagy 
also plays a role in the destruction of some 
bacteria within the cell and helps to get 
rid of pathogens. Recently, autophagy has 
also been related to cell death, either as a 
part of apoptosis (Xue et al., 1999) or as 
a separate, non-apoptotic death mode that 
is independent of caspases. For example, 
the cells of embryonic interdigital tissue 
are dying by an autophagic ultrastructure 
(Lockshin and Zakeri, 2001). Autophagic 
features have also been reported in several 
pathological tissues, such as excitotoxically 
dying neurons (Portera-Cailliau et al., 
1997). Importantly, autophagic death is 
often triggered in cells where caspases are 
blocked or can not be activated. Indeed, the 
PCD in most tissues of caspase-3, caspase-
9, or Apaf-1 knockout mice occurs with 
autophagic ultrastructure (Oppenheim et 
al., 2001; Oppenheim et al., 2008). Also, 
cells in which caspases are blocked (e.g. 
Bax/Bak double-defi cient fi broblasts) die 
with autophagic features when exposed to 
apoptotic stimuli (Shimizu et al., 2004). 
Death of such cells is dependent on 
autophagic genes Atg5 and beclin-1, and 
can be inhibited by the autophagy inhibitor 
3-methyladenine (Shimizu et al., 2004). 
     Thus, autophagy can be both a survival-
promoting and death-promoting process. 
It is not yet fully clear when and to what 
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extent autophagy really participates in the 
programed cell death in mammals. Most 
probably there could be a threshold at 
which autophagy switches from survival-
promoting to a death-promoting process 
(Baehrecke, 2005; Maiuri et al., 2007). 
1.6.2. Other non-apoptotic cell death 
pathways
Several other non-apoptotic programed 
death pathways have been described, but 
these are very poorly studied. 
Paraptosis Hyperactivation of the tyrosine 
kinase receptor insulin-like growth factor 
I receptor induce a non-apoptotic form of 
cell death called paraptosis, whose activity 
is mediated by mitogen-activated protein 
kinases (MAPKs) and inhibited by AIP-1/
Alix (Sperandio et al., 2000; Sperandio et 
al., 2004). The cells dying paraptotically 
exhibit extensive cell vacuolization and 
swelling of the mitochondria and ER, 
thereby resembling necrosis like death 
(Clarke, 1990). Caspases were not activated 
during paraptosis and Bcl-xL did not block 
the death in either the primary culture or 
cell lines, suggesting that this type of cell 
death is fundamentally different from 
apoptosis. At present, it is unclear whether 
paraptosis represents a route of cell death 
that is really distinct from all others.  
PARP-dependent cell death Dawsons 
and colleagues demonstrated that  after 
the activation of poly-(ADP-ribose) 
polymerase-1 (PARP-1) and the 
translocation of AIF from the mitochondria 
to the nucleus, the death appears to be 
caspase-independent (Yu et al., 2002). 
Agents that induced DNA damage can 
induce this form of programed cell death. 
PARP-dependent cell death displays a 
morphology and biochemistry that is 
distinct from the classic programed cell 
death.
Oncosis Oncosis has been defi ned as a 
form of cell death accompanied by cellular 
swelling, organelle swelling, and increased 
membrane permeability. It has been 
regarded as passive cell death, occurring 
only after severe tissue injury brought 
about by ischemia (Trump et al., 1997).  It 
is thought to be mediated by the failure of 
the plasma membrane ionic pumps. One 
potential mediator of oncosis could be a 
calpain-family protease, which suggests 
that oncosis maybe related to calcium-
activated necrosis-like cell death.
Necroptosis Recently a novel non-
apoptotic death mode termed necroptosis 
was described in cultured cells 
(Vercammen et al., 1998; Holler, 2000; 
Kawahara et al., 1998; Degterev et al., 
2005). This type of cell death does not 
involve the pro-apoptotic proteins such 
as cytochrome c, caspases, or Bcl-2 
family members. Morphologically it has 
many features of classical necrosis, and is 
therefore described as a sort of programed 
necrosis. Necroptosis cannot be blocked 
by the inhibitors of apoptosis but, instead, 
by small molecule compounds called 
necrostatins (that, in turn, do not block 
apoptosis) (Degterev et al., 2005; Wang et 
al., 2007; Zheng et al., 2008; Degterev et 
al., 2008). RIP1, one member of the RIP 
kinase family bears a C-terminal death 
domain, and an intermediate domain. 
The death domain of RIP1 is important 
for binding to death receptors such as 
TNF-receptor 1, TRAIL-receptor 1, and 
TRAIL-receptor 2, and also to death 
domain-containing adaptor proteins such 
as TRADD and FADD. Necrostatins 
directly bind and inhibit RIP1 showing 
that it is a component of necroptototic 
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pathway (Vandenabeele et al., 2008). 
     In the pathological situations, the cells 
often die via mixed death morphologies 
that include both apoptotic and non-
apoptotic pathways, in particular necrotic 
and/or autophagic features, depending 
on the nature and intensity of the disease 
or trauma (Golstein and Kroemer, 2007; 
Levine and Kroemer, 2008). Most 
probably these cannot be defi ned as 
separate cell death modalities (Kroemer et 
al., 2008). Cells can die many ways and 
new modes are likely to still be described. 
The pathways that mediate the non-
apoptotic death, as well as their biological 
meaning are, however, still very poorly 
understood. 
1.7. Model of neurotrophic factor-
deprived neurons
The target-derived neurotrophic factor 
model supposes that during PCD, the 
neurons are intrinsically apoptotic, and the 
apoptosis is actively suppressed by target-
derived neurotrophic factors. Neonatal 
sympathetic neurons from the superior 
cervical ganglion (SCG) are well-suited 
for studying this model. The PCD of these 
neurons occurs during the fi rst postnatal 
week when about half of the neurons die. 
This survival depends almost completely 
on NGF, as virtually all SCG neurons 
are lost in the NGF or TrkA knockout 
mice (Crowley et al., 1994; Fagan et al., 
1997). Deprivation of NGF from neonatal 
SCG neurons in vitro recapitulates their 
ontogenetic death in vivo. Deprivation of 
NGF from cultured sympathetic neurons 
leads to the following events. Transcription 
factor c-jun becomes phosphorylated and 
the protein level of c-jun also increases 
(Estus et al., 1994; Ham et al., 1995; 
Virdee et al., 1997; Eilers et al., 1998). 
Inhibition of the JNK (c-jun N-terminal 
kinase) pathway protects the neurons 
from death (Harris et al., 2002). The 
proapoptotic protein Bax is translocated 
from the cytosol to the mitochondria 
(Deckwerth et al., 1996; Putcha et al., 
1999) and cytochrome c is released 
from the mitochondria into the cytosol 
(Deshmukh and Johnson, 1998; Neame et 
al., 1998; Martinou et al., 1999) to form 
a complex with Apaf-1 and procaspase-9. 
As a result, caspase-9 and -3 (Deshmukh 
et al., 2000; Deshmukh et al., 2002), but 
also caspase-2 (Troy et al., 2001) are 
activated. All of these events are critically 
required for the NGF deprivation-induced 
death in vitro. The neurons then exhibit 
several characteristic morphological 
changes, including cytoplasmic shrinkage, 
soma degeneration, neurite fragmentation, 
and chromatin condensation (Martin et 
al., 1988; Pittman et al., 1993; Edwards 
and Tolkovsky, 1994; Xue et al., 1999), 
and they fi nally die in the culture by 
secondary necrosis. Thus, the NGF-
deprived SCG neurons basically die via 
the classical intrinsic pathway (Wright 
et al., 2006). Several neuron-specifi c 
features have also been described in the 
death of NGF-deprived SCG neurons. For 
example, differently from non-neuronal 
cells, the mere cytosolic localization of 
cytochrome c in the non-apoptotic NGF-
maintained neurons is not able to trigger 
apoptosis. Microinjected cytochrome c 
kills the neurons only when they are also 
deprived of NGF. This phenomenon, called 
“competence”, is most probably related 
to strong interaction of caspases with a 
natural inhibitor XIAP (X-linked inhibitor 
of apoptosis), and also with the low levels 
of Apaf-1 in SCG neurons (Deshmukh and 
Johnson, 1998; Potts et al., 2003; Potts 
et al., 2005). Also, these neurons (as all 
neurons) do not express Bak but, instead, 
a BH3-only splicing variant N-Bak (Sun et 
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al., 2001; Sun et al., 2003). 
     Although most of peripheral neurons that 
die during PCD are thought to do so due to 
of lack of neurotrophic support, deprivation 
of SCG neurons from neurotrophic factors 
other than NGF or death mechanisms of 
other neurotrophic factor-derived neurons 
are less studied. Deprivation of trophic 
factors from motoneurons and sensory 
neurons has been studied (Raoul et al,. 
1999; Dolcet et al., 1999; Freeman et al., 
2004). Serum deprivation is also a potent 
inducer of apoptosis in vitro for many 
different cell types including neurons 
(Atabay et al., 1996; Huang et al., 2000; 
Charles et al., 2005), but the underlying 
mechanism is also poorly understood. 
1.8. Active modes of death
The death of NGF-deprived SCG neurons 
seems to in pricinple, be a passive process. 
The death program of these neurons is 
believed to lack some unknown constraints 
that normally keep the program repressed, 
and thus requires continuous suppression 
by NGF. Therefore, the signaling of NGF-
bound TrkA by activated Akt kinase, B-Raf 
(Encinas et al., 2008), and other survival-
promoting proteins somehow repress the 
Figure 8. Model for apoptosis induced by the dependence receptor. When in the presence 
of ligand, dependence receptors mediate signal transduction that affects either differentiation 
or migration but may also inhibit the pro-apoptotic activity of these receptors. When unbound 
(or bound by a non-trophic ligand), however, a pro-apoptotic signal occurs via negative signal 
transduction. In at least some cases, this is mediated by a conformational change in the receptor, 
proteolytic cleavage, resulting in the release of pro-apoptotic dependence peptides. Adapted from 
Mehlen and Bredesen (2004).
Review of the Literature
25
death machinery. NGF withdrawal, causing 
cessation of the survival signaling, just 
passively releases the death program. Such 
release of apoptosis clearly opposes the 
theory that death receptors actively initiate 
death at the DISC. Recently, several other 
active modes of death triggering have been 
described, several also in neurons. The 
best studied of these are the dependence 
receptors and pro- neurotrophins.
1.8.1. Dependence receptors
Recently, a new family of functionally 
related receptors has been described 
as dependence receptors (Mehlen and 
Bredesen, 2004; Bredesen et al., 2004; 
Mehlen and Thibert, 2004). These proteins 
induce two completely opposite signals 
depending on the ligand availability. In 
the presence of the ligand, these receptors 
have positive effects on the cell survival, 
proliferation, differentiation etc., however 
when the ligand is absent, these receptors 
actively induce programed cell death. 
More than 10 receptors have been shown 
to display these two opposite activities: 
p75NTR (Rabizadeh et al., 1993), the netrin-
1 receptors DCC (Forcet et al., 2001), 
UNC5H1, UNC5H2 and UNC5H3 (Llambi 
et al., 2001), the androgen receptor (Ellerby 
et al., 1999), the receptor for GDNF 
family ligands, Ret (Bordeaux et al., 2000; 
Canibano et al., 2007), integrins (Stupack 
et al., 2001; Ruoslahti and Reed, 1994), 
the receptor for Sonic hedgehog, Patched 
(Thibert et al., 2003) and the receptor for 
neogenin, RGM (Matsunaga et al., 2004). 
All of these receptors when deliganded, 
trigger cell death in a novel active manner 
that, in most cases, involves proteolytic 
cleavage of their intrcellular domain and 
release of the dependence domain that can 
actively trigger death. Although the details 
of activation of the deliganded receptor are 
still poorly understood, the current model 
proposes cleavage of the receptor from 
one or two sites by specifi c caspases. The 
released dependence domain can activate 
the apoptotic caspases that kill the cell. 
Deletion of this domain or mutation of 
the caspase cleavage sites is suffi cient to 
block the killing activity (Figure 8). The 
cytoplasmic domain of netrin receptor DCC 
activates caspases in a cell-free system in 
the presence of cytosol that is depleted of 
cytochrome c, a novel mechanism (Furne 
et al., 2006). The caspase-activating 
mechanism of other dependence receptors 
is still poorly studied. Importantly, the 
deliganded dependence receptors are 
essential in killing the metastasing tumor 
cells that migrate out of the ligand-
expressing area, and could be potential 
targets in tumor treatment (Mehlen and 
Thibert, 2004; Bernet and Mehlen, 2007). 
1.8.2. Pro-neurotrophins and P75NTR
A common-shared receptor of the 
neurotrophins is p75NTR. It belongs to the 
superfamily of receptors that includes 
the tumor necrosis factor receptors and 
Fas (Chao, 1994). On one hand, p75NTR 
participates in the formation of high-
affi nity complexes with neurotrophins 
and the respective Trk receptors and 
thereby facilitates positive signaling of 
the neurotrophins. On the other hand, 
p75NTR can also actively induce cell death 
(Nykjaer et al., 2005). The mechanism of 
death-promoting activities of p75NTR can 
also be different (Bredesen et al., 2005). 
In some studies, p75NTR was shown to act 
as a dependence receptor, inducing cell 
death when not bound with the ligand, 
and death was blocked by binding of the 
ligand (Rabizadeh et al., 1993; Barrett and 
Bartlett, 1994; Rabizadeh et al., 1993). 
Importantly, as shown by overexpressed 
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p75NTR without bound ligand, cleavage 
of the cytoplasmic domain of p75NTR and 
release of a “chopper” domain in the 
juxtamembrane region mediates cell death 
(Coulson et al., 2000). Increasing evidence 
also shows that p75NTR can trigger death 
upon binding of a ligand, in particular pro-
NGF or pro-BDNF (Lee et al., 2001; Teng 
et al., 2005), thus acting as a death receptor. 
Neurotrophins are synthesized as longer 
proforms. Earlier the pro-neurotrophins 
were considered inactive proteins that 
are activated by proteolytic removal of 
the pro-sequence. Recently it was shown, 
however, that the pro-neurotrophins 
can have an independent, pro-apoptotic 
function (Lee et al., 2001). In particular, 
the proforms activate p75NTR to induce 
apoptosis, whereas mature forms mainly 
activate Trk receptors to promote survival. 
Sortilin is associated with p75NTR and pro-
neurotrophins to form a signaling complex 
essential for the induction of apoptosis 
(Nykjaer et al., 2004).  Studies on sortilin 
knockout mice indicate that sortilin has 
distinct roles in pro-neurotrophin-induced 
apoptotic signaling in pathological 
conditions (Jansen et al., 2007). 
Interestingly, binding of pro-neurotrophins 
to p75NTR can also cause the cleavage of 
its transmembrane domain by gamma-
secretase. This cleavage facilitated nuclear 
translocation of the neurotrophin receptor 
interacting factor (NRIF). The cleavage of 
p75NTR and nuclear translocation of NRIF 
were required for apoptosis of sympathetic 
neurons by pro-BDNF or BDNF binding 
in the absence of NGF (Kenchappa et al., 
2006). Studies disagreeing with the pro-
apoptotic function of p75NTR also exist. 
For example, the cytoplasmic region of 
p75NTR may not translocate to the nucleus, 
because it was not detected in the nucleus 
even after viral over-expression (Hébert 
et al., 2006). P75NTR also has many other 
activities (Nykjaer et al., 2005, Bredesen 
et al., 2005). In summary, p75NTR may 
induce death as a dependence receptor or 
as a death receptor, possibly depending on 
the cellular context. 
1.9. One cell, multiple cell death 
pathways 
It is clear that there are more programed 
death pathways than just the “two main” - 
extrinsic and intrinsic apoptotic pathways. 
Although currently poorly described, 
the “novel” pathways may also have 
important roles in vivo, and most likely 
more pathways will be discovered. The 
same death stimulus can trigger different 
death pathways in different cell types (e.g. 
deprivation of GDNF from sympathetic 
and dopaminergic neurons, paper I and 
IV). Also, the same cell can die differently 
in response to different death stimuli. For 
example, treatment of lymphocytes with 
genotoxic compounds kills them via the 
mitochondrial pathway, whereas activation 
of Fas activates the death receptor pathway 
in the same cells. Thus, cells possess more 
than one death pathway. In vivo relevance 
of this concept is well illustrated in mice 
defi cient of the main components of the 
intrinsic apoptotic pathway: Apaf-1, 
caspase-3, caspase-9, or knock-in mice 
with non-apoptotic cytochrome c. In these 
mice, the developmental apoptosis in 
most cells of the nervous system (except 
in the forebrain precursors) still occurred 
but via different, non-apoptotic pathway 
that includes cytoplasmic vacuolization 
and increased autophagy (Cecconi et 
al., 1998; Roth et al., 2000; Zaidi et al., 
2001; Hao et al., 2005; Oppenheim et al., 
2008). Cultured sensory neurons switch 
to a death pathway that uses lysosomal 
proteases instead of caspases, when the 
caspase inhibitor is applied (Isahara et al., 
Review of the Literature
27
1999; Agerman et al., 2000). Studies of 
Bcl-xL/caspase-9 double knockout also 
give evidence of multiple death pathways 
in the same cells (Zaidi et al., 2001). 
Thus, upon failure of the default apoptotic 
pathway, most of the neurons switched to 
an alternative death mode, showing that 
they possess and can use several death 
machineries.
A notable example of non-apoptotic 
cell death, necroptotic cell death was also 
discovered in the cells that were under 
constant death stimulus of TNF but had 
the main apoptotic pathway blocked by 
caspase inhibitors. In these conditions, 
the cells switched to a non-apoptotic 
pathway and died despite of caspase 
inhibition. Necroptosis can be blocked by 
specifi c compounds, necrostatins that do 
not block classical apoptosis. Conversely, 
necroptosis cannot be blocked by the 
inhibitors of apoptosis, such as Bcl-2 
family members or caspase inhibitors. 
Importantly, necroptosis seems to be 
involved in many forms of pathological 
neuronal death (Vandenabeele at al., 
2008; Festjens at al., 2007; Degterev et 
al., 2008), 
The reason why just one death 
pathway in all cells in all situations is not 
suffi cient is not understood. Most probably 
the different cell types have their “default” 
death pathway in response to the death 
stimuli that they normally encounter in their 
natural environment. The other pathways 
could be “spare pathways” that are used 
when the main one fails or is not available. 
The kinetic parameters are also one 
reason for the existence of different death 
programs. For example, the death receptor 
pathway, with fewer checkpoints, kills the 
cells more rapidly than the mitochondrial 
pathway. Such rapid action is required to 
fi ght against invading pathogens, whereas 
the slower intrinsic pathway gives the cell 
more opportunities to cope with the death-
causing situation. The same could also be 
true for other active modes of cell death. 
Also, the differentiation status of cells 
could dictate the preference of the death 
program. Some differentiation programs 
may include or exclude the expression of 
the death-mediating proteins that could 
determine the pathway choice in the 
death inducing situation. Indeed, there 
are increasing bodies of evidence that 
many, if not all, death-mediating proteins 
also (or even primarily) have vital, non-
apoptotic functions and could therefore 
be differentially expressed or regulated in 
different cell types (Galluzzi et al., 2008; 
Peter, 2007; Wallach et al., 2008). 
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2. AIMS OF THE STUDY
Neurotrophic factors promote the survival of both peripheral and central neurons in vivo 
and in vitro. Defi ciency of these factors leads to ontogenetic death of these neurons. The 
well-characterized model for studying neuronal death is deprivation of NGF from the 
cultured sympathetic neurons. Other types of neurons as well as deprivation of other 
neurotrophic factors, are poorly studied in this respect. The aim of this study was to 
compare the death machineries triggered in different neuronal populations by removal 
of different neurotrophic factors. 
1.  To compare the death programs triggered by withdrawal of two different neurotrophic 
factors, GDNF or NGF, from the sympathetic neurons. 
2.  To test the hypothesis that TrkC acts as a dependence receptor in the death of NT-3-
deprived sensory neurons.
    
3.  To develop a new assay technique for studying the death pathways in apoptotic 
dopaminergic neurons.
4.  To study the death pathways activated in the dopaminergic neurons by the deprivation 
of GDNF or BDNF.
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3. MATERIALS AND METHODS
3.1. Cell cultures and survival assays (I, 
II, III and IV)
SCG from postnatal day 1-2 Han/Wi 
strain rats  or NMRI strain mice were 
digested with collagenase (2.5mg/ml; 
Worthington), dispase (5mg/ml; Roche 
Molecular Biochemicals) and trypsin 
(10mg/ml; Worthington) for 45 minutes at 
37°C and dissociated mechanically with 
a siliconized glass Pasteur pipette. Non-
neuronal cells were removed by four hours 
preplating. The neurons were grown 5-6 
days in vitro on poly-ornithine/ laminin-
coated plastic dishes or glass coverslips in 
a 1:1 ratio of mixture F-12 and Dulbecco´s 
modifi ed Eagle´s medium (DMEM) (Life 
Technologies,Inc.) containing 3% fetal 
calf serum (Hyclone), serum substitute 
and 30ng/ml NGF (Promega) or 100ng/ml 
GDNF (PeproTech). To reduce the number 
of non-neuronal cells, 1 μM cytosine 
arabinoside (Sigma-Aldrich) was added to 
the culture medium.
DRG neurons were prepared from 
embryonic day 16-17 NMRI strain mice, 
treated with 1% trypsin (Worthington) for 
15 min and dissociated mechanically. The 
neurons were grown on polyornithine-
laminin-coated dishes with either 10 ng/ml 
of human NT-3 (PeproTech) or 30 ng/ml 
of 2.5S mouse NGF (Promega).  
The midbrain fl oors were dissected 
from the ventral mesencephali of 13-day 
NMRI strain mouse embryos. Tissues 
were incubated with 0.5% trypsin (ICN 
Biomedical, Inc.) in HBSS (Ca2+/Mg2+ 
free) (Invitrogen/Gibco) for 15 min at 
37°C, then mechanically dissociated using 
a large fi re-polished Pasteur pipette. The 
cells were then plated onto culture dishes 
coated with poly-L-ornithine (Sigma-
Aldrich) and were grown in DMEM/F12 
medium (InVitrogen/Gibco) containing 
N2 supplement (Invitrogen/Gibco) for 5 
days with GDNF (100 ng/ml) (Amgen Inc, 
CA) or BDNF (50 ng/ml) (R&D systems, 
Inc.).
Mouse embryonic fi broblast 3T3 cells 
were grown in DMEM medium with 10% 
fetal calf serum. The cells with 50-80% 
confl uency were used for transfection or 
other experimental treatments.
To remove the trophic factors, the 
cultures were washed gently three times 
with trophic factor-free medium. In 
addition, function-blocking antibodies 
were added. The compounds of interest 
were added and the initial number of 
neurons counted immediately after 
neurotrophic factor deprivation.  Living 
neurons were counted daily by a “blind” 
experimenter who was not aware of the 
identity of experimental groups.
3.2. Reverse transcription-polymerase 
chain reaction (RT-PCR) (IV)
Dopaminergic neurons were cultured for 5 
days in vitro and deprived or not deprived 
of the factors for 24 hours with or without 
BAF. Total RNA from dopaminergic 
neurons, 3T3 (positive control, expressing 
both Fas and Fas ligand) or CHO (negative 
control) cells was isolated by Micro Scale 
RNA Isolation kit (Ambion) including 
DNase I digestion, according to the manual 
instructions. 200-500 ng of total RNA was 
reverse transcribed using the Transcriptor 
First Strand cDNA Synthesis Kit (Roche) 
and the cDNA was used directly for 
PCR. 2 μl of cDNA from each sample 
was amplifi ed by PCR with the Expand 
High Fidelity PCR system (Roche). 
The following primers were used. Fas: 
forward: 5’-GTGTTCGCTGCGCCTC-3’; 
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reverse 5’- GGTTCTGCGACATTCGGC-
3’ (Lesne et al., 2002); Fas ligand: forward 
5’- TTTCATGGTTCTGGTGGCTCTGGT-
3’; reverse 5’- 
AGCGGTTCCATATGTGTCTTCCCA-
3’. PCR was performed after an initial 
denaturation of 5 min at 95°C, followed by 
36 cycles of 30 s denaturation at 95°C, 30 
s annealing at 60°C, and 30 s extensions at 
72°C. As the negative controls, RT reaction 
was omitted from the 3T3 sample, or the 
whole procedure was performed in water 
without adding cDNA.
3.3. Microinjection and transfections 
(I, II, III and IV)
SCG or DRG neurons were pressure-
microinjected with 50 ng/μl of expression 
plasmids together with 10 ng/μl of reporter 
plasmid for an enhanced green fl uorescent 
protein (eGFP) (Clontech, France) as 
an indicator of successful injection. The 
corresponding empty vector (pcDNA3, 
PCR3.1 or pMV2B) as well as an un-
injected control were always included. 
When the neurotrophic factor-deprived 
neurons were analyzed, the factor-
maintained un-injected neurons were 
always included to show that the neurons 
do not die due to poor culture conditions. 
Neurons surviving after injection were 
counted 4-6 h later according to the map 
drawn with the help of squares scratched 
to the bottom of the culture dish and 
considered as initial neurons. The next 
morning, the few living injected neurons 
that did not show eGFP fl uorescence were 
subtracted from the initial neurons. On 
average, 25-80 neurons were successfully 
injected per experimental point. All 
experiments were repeated at least three 
times on independent cultures. 
     Midbrain cultures grown 5 days in vitro 
with GDNF or BDNF were transfected with 
the calcium phosphate co-precipitation 
technique using the Ca-P kit (InVitrogen, 
CA) according to manufacturer’s 
instructions. Plasmids of interest at 1 g/
ml were co-transfected with eGFP at 0.2 
μg/ml. At that ratio, virtually all eGFP-
expressing neurons co-express the co-
transfected plasmid. The relevant empty 
vectors (pCR3.1, pMV2B or pCDNA3) 
without the insert were always included 
as mock-controls. The factors were 
deprived the day after transfection. The 
number of fl uorescent (eGFP-expressing) 
neurons was counted “blindly” from each 
dish immediately after factor deprivation 
(initial) and at the third day (fi nal). The 
results were expressed as percent of 
initial fl uorescent neurons. To exclude 
eGFP-expressing non-dopaminergic 
neurons, the cultures were stained with 
tyrosine hydroxylase (TH) antibodies at 
the end of experiment and the number 
of eGFP-positive, TH-negative neurons 
were subtracted from the initial and fi nal 
number. All experiments were repeated at 
least three times on independent cultures. 
The 3T3 cells at 50-80% confl uence 
were transfected with the indicated 
plasmids or with the mock vector using 
Lipofectamine 2000 (Life Technologies, 
Inc.).
 
3.4. Immunochemistry (I, IIIand IV)
Rat or mouse neurons were grown on 
glass coverslips, fi xed with 4% PFA in 
phosphate-buffered saline (PBS) for 15 
min, permeabilized  with 0.3% Triton 
X-100 (Sigma-Fluka, Switzerland) and 
stained with the indicated antibodies. The 
specimens were mounted in Vectashield 
(Vector Laboratories, UK). The images 
were captured at RT with epifl uorescence 
or confocal microscopy, and processed 
with Adobe Photoshop software.
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3.5. Immunoblot and co-
immunoprecipitation (II, III and IV)
Midbrain cultures grown with GDNF 
or BDNF for 5 days in vitro or NT-3 
dependent DRG neurons were lyzed in 
the 2 % SDS lysis buffer. Lysates from the 
3T3 cells or cortical cultures of embryonic 
mice were prepared in the same way. 
The proteins were separated on the 
sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) and 
transferred to the nitrocellulose fi lters 
by standard procedures. The fi lters were 
probed with the indicated antibody.
For the co-immunoprecipitation 
experiments, midbrain neurons were 
cultured for 5 days in vitro with GDNF or 
BDNF and transfected with an expression 
plasmid for mouse Fas together with eGFP 
according to Yu and Arumäe (2008). After 
two days the cells were lyzed as described 
previously by Segura et al. (2007). Fas 
was precipitated by biotin-coupled anti-
Fas antibody (BD Biosciences) or control 
biotin-coupled anti-GFRα2 antibody (BD 
Biosciences) and the immunocomplexes 
were collected with Neutravidin (Thermo, 
MA). Immunoblot analysis was performed 
right after immunoprecipitation.
3.6. Electron microscopy analysis (I)
SCG cultures were fi xed two days after factor 
deprivation with 2% of glutaraldehyde. The 
cultures were processed for transmission 
electron microscopy. To estimate the size 
of the mitochondria from GDNF- or NGF-
deprived neurons, mitochondria, at a fi nal 
magnifi cation of 33,000x, were manually 
traced onto transparencies that were 
scanned. A cross-sectional area of the 
mitochondria was measured using Image-
Pro Plus version 3.0.
3.7. Statistical analysis (I, II, III and 
IV)
Statistical signifi cance of the differences 
was estimated by one-way ANOVA and 
post hoc Tukey’s test or by two-tailed 
Student´s t test with two-sample unequal 
variance. The null hypothesis was rejected 
at p<0.05.
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4. RESULTS
Although neuronal death caused by 
neurotrophic factor defi ciency is 
most probably a broadly occurring 
developmental phenomenon (Oppenheim, 
1991), its molecular and cellular pathways 
have been systematically described 
mainly for NGF-deprived sympathetic 
neurons. Other neuronal populations, as 
well as deprivation of other neurotrophic 
factors are poorly studied. The main goal 
of this study was to describe the death 
pathways activated by the withdrawal of 
neurotrophic factors other than NGF in 
different neuronal populations.
4.1. GDNF-dependent sympathetic 
neurons die via a non-mitochondrial 
pathway which requires caspase 
activation (I)
Although almost all sympathetic neurons 
from the superior cervical ganglion require 
NGF for the survival, a subpopulation is 
additionally dependent on GDNF. These 
neurons are, however, very poorly studied. 
We studied the death of GDNF-deprived 
sympathetic neurons cultured in vitro and 
compared them to NGF-deprived sister 
cultures. Removal of GDNF or NGF from 
the rat sympathetic neurons for 72 hours 
leads to the death of about 80% of the 
respective factor-dependent neurons. To 
study how these neurons die, we checked 
the components of the core mitochondrial 
apoptotic machinery, such as cytochrome 
c, Bax, caspase-9, and caspase-3. Staining 
the neurons with cytochrome c antibody 
showed that removal of NGF dramatically 
reduced the number of the neurons with 
punctate cytochrome c localization, as 
shown by others (Deshmukh and Johnson, 
1998; Neame et al., 1998; Martinou 
et al., 1999). In contrast, only a small 
fraction of GDNF-deprived neurons had 
diffuse cytosolic cytochrome c staining, 
whereas the vast majority had punctate, 
mitochondrial cytochrome c staining. 
Overexpression of Ku70, a protein 
which binds the NH2 terminus of Bax, 
and thereby blocks its translocation to 
the mitochondria (Sawada et al., 2003), 
did not protect GDNF-deprived neurons, 
although, it signifi cantly blocked the death 
of NGF-deprived neurons. To check the 
involvement of caspases, we overexpressed 
the respective dominant-negative mutants 
in factor-deprived neurons. Blocking 
of caspase-9 and caspase-3, the central 
caspases of the mitochondrial pathway, 
failed to inhibit the death of GDNF-
deprived neurons, although the death of 
NGF-deprived neurons was signifi cantly 
blocked, as expected (Deshmukh et al., 
2002; Deshmukh et al., 2000; Deshmukh 
et al., 2002; Harris et al., 2002; Troy et 
al., 2001). These data showed that the 
core elements of classical mitochondrial 
pathway are not activated in GDNF-
deprived sympathetic neurons. To confi rm 
this conclusion, we also overexpressed 
anti-apoptotic Bcl-2 family member Bcl-
xL, which is shown to block mitochondrial 
death pathway (Tsujimoto, 1998). Bcl-xL 
did not protect GDNF-deprived neurons, 
but rescued most of the NGF-deprived 
neurons. The absence of cytochrome c 
release, together with a failure to observe 
the role of Bax, caspase-9, -3, and Bcl-xL, 
suggests that the mitochondrial pathway 
is not activated in GDNF-deprived 
sympathetic neurons.
The broad-range caspase inhibitor, 
BAF, almost completely blocked the death 
of both NGF- (Deshmukh et al., 1996, 
2000; Martinou et al., 1999) and GDNF-
deprived neurons. To clarify the relevant 
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caspases in the GDNF-deprived neurons, 
we overexpressed dominant-negative 
mutants of caspase-2, -6, -7, and -8 in 
the GDNF-deprived and NGF-deprived 
neurons. Blocking caspase-2,-3, and -
9, and to lesser extent, caspase-6 and -7 
signifi cantly inhibited the death of NGF-
deprived neurons. But only dominant 
negative mutants of caspase-2 and, to 
lesser extent, caspase-7 inhibited the death 
of GDNF-deprived neurons.
To study the activation of the 
transcription factor c-jun, we stained GDNF- 
or NGF-deprived neurons with antibodies 
to c-jun phosphorylated at serines 63 or 73. 
Removal of GDNF signifi cantly increased 
the number of nuclei immunopositive for 
phosphorylated serine 73. The number of 
nuclei positive for phosphorylated serine 
63 remains unchanged. In sister cultures, 
deprivation of NGF dramatically induced 
phosphorylation of serine 63 of c-jun as 
previously shown (Ham et al., 1995; Virdee 
et al., 1997; Eilers et al., 1998; Harris et 
al., 2002). Phosphorylation of c-jun is 
also catalyzed by the c-jun NH-2 terminal 
kinases whose activity is in turn regulated 
by several upstream kinases, including the 
mixed lineage kinases (MLK). We treated 
GDNF- or NGF-deprived neurons with 
CEP-1347, which is a selective inhibitor 
of MLK (Maroney et al., 2001). Almost 
all NGF-deprived neurons were rescued 
by CEP-1347 at 72 hours after deprivation 
as previously described (Maroney et al., 
1999; Harris et al., 2002). CEP-1347 also 
rescued GDNF-deprived neurons with the 
same effi ciency. Finally we tested whether 
c-jun was necessary for the death of factor-
deprived neurons. We overexpressed 
a dominant-negative c-jun mutant 
FLAG∆169 in GDNF- or NGF-deprived 
neurons. After 72 hours about 60% of 
NGF-deprived neurons were rescued as 
previously described (Ham et al., 1995; 
Eilers et al., 1998). A similar percentage of 
GDNF-deprived neurons was rescued by 
overexpressed FLAG∆169. In summary, 
activation of c-jun is necessary for the 
death of GDNF-deprivation.
Overexpression of a dominant-
negative mutant of FADD, an adapter that 
links pro-caspase-8 to most death receptors 
(Strasser and Newton, 1999; Vincenz, 
2001; Peter and Krammer, 2003; Peter 
et al., 2007) protected neither GDNF- 
nor NGF-deprived neurons. In addition, 
overexpression of dominant-negative 
caspase-8 did not affect the death of these 
two neuronal populations. Thus, we did 
not fi nd any evidence for the activation 
of death receptor pathway in GDNF- or 
NGF-deprived sympathetic neurons.
We also investigated the ultrastructural 
changes caused by GDNF- or NGF-
deprivation. We found that the number of 
autophagic profi les was greatly increased 
in GDNF-deprived neurons, but not in 
NGF-deprived neurons. The mitochondrial 
structure became apoptotic in NGF-
deprived neurons, but in GDNF-deprived 
neurons, the mitochondria remained 
orthodox. 
In summary, we found that GDNF-
deprived sympathetic neurons die via a 
novel non-mitochondrial, MLK, c-jun, 
and caspase-dependent pathway that had 
not yet been described. Removal of NGF 
from sympathetic neurons in the same 
conditions, however, activates the classical 
mitochondrial death pathway.
4.2. The dependence receptor activity 
of TrkC is necessary for the death of 
NT-3-deprived sensory neurons (II)
As another pair of neurotrophic factor 
and neurons, we turned to NT-3-deprived 
sensory neurons from the embryonic 
dorsal root ganglia. This study was carried 
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out in collaboration with Patrick Mehlen 
and colleagues (Centre Léon Bérard, 
Lyon), and was inspired from the model 
of dependence receptors developed by 
that group (Mehlen and Bredesen, 2004; 
Mehlen and Thibert, 2004). Our main goal 
here was to test the hypothesis that removal 
of NT-3 (deligation of its receptor TrkC) 
leads to the caspase-mediated cleavage 
of the cytoplasmic domain of TrkC and 
the cleaved fragment activates apoptotic 
caspases. If so, then TrkC is a novel 
dependence receptor. The group in Lyon 
tested this model on non-neuronal cells 
(not shown here), whereas we addressed it 
in the primary sensory neurons.
DRG neurons from the embryonic 
mice were cultured with NT-3 or NGF for 
5 days. Deprivation of these factors leads 
to death of about 60-70% of the neurons 
after 72 hours. By immunoblot we found 
that deprivation of NT-3 can induce 
cleavage of TrkC, and this cleavage can be 
blocked by the caspase inhibitor BAF. The 
fragment was recognized by the antibodies 
to the extracellular domain of TrkC and is 
thus different from that predicted by the 
model. Most probably there are several 
cleavages of the receptor upon NT-3 
removal. We then turned to a research 
tool that dominantly inhibits cleavage of 
de-ligated TrkC: a cytoplasmic domain of 
TrkC with mutated caspase cleavage site 
(TrkC IC D641N). Such constructs with 
similar design have been used to inhibit 
other dependence receptors (Ellerby et al., 
1999; Forcet et al., 2001; Thibert et al., 
2003). Overexpression of TrkC IC D641N 
dramatically increased survival of NT-3 
deprived neurons, although it did not affect 
the death of NGF-deprived neurons. To 
exclude the possible role of tyrosine kinase 
domain, that could be auto-activated when 
separated from the rest of the protein, 
and provide the survival signal, we also 
microinjected the TrkC IC D641N bearing 
an additional kinase-inactivating mutation 
D679N. This mutation did not abolish 
the death-suppressing activity of TrkC 
IC D641N in NT-3-deprived neurons. 
To further demonstrate the role of TrkC 
cleavage in the death of NT-3-deprived 
neurons, we suppressed the endogeneous 
receptor by a specifi c RNAi and replaced 
it by ectopic expression of uncleavable 
or wild-type TrkC. Replacement of 
endogenous TrkC by uncleavable TrkC 
signifi cantly inhibited the death of NT-3-
deprived neurons, whereas replacement 
with wild-type TrkC had no effect. 
These data together with the data 
provided by the Lyon group on the non-
neuronal cells (not shown in this thesis) 
prove that TrkC is a new dependence 
receptor. Thus, NT-3 deprivation-induced 
cell death is not only due to the loss of 
survival signals, but also to active cell 
death stimulus triggered by unbound TrkC. 
These data also show that NT-3-deprived 
sensory neurons die differently than the 
NGF-deprived ones.
4.3. A survival assay of transiently 
transfected dopaminergic neurons to 
analyze the apoptotic proteins in these 
neurons (III)
Our results with GDNF-deprived 
sympathetic neurons prompted us to turn 
to another population of GDNF-dependent 
neurons, the dopaminergic neurons 
from the embryonic midbrain. Our main 
goal was to test whether the removal of 
GDNF triggers the same death pathway 
in different neuronal types, i.e does the 
de-ligation of GDNF receptor Ret always 
trigger the same pathway. Moreover, 
the dopaminergic neurons degenerate 
in Parkinson’s disease and in several 
studies, GDNF considerably improved 
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the symptoms (Oo et al., 2003; Oo et al., 
2005; Gill et al., 2003; Slevin et al., 2005; 
Lang et al., 2006; Patel and Gill, 2007). 
Understanding the mechanism of death 
due to GDNF deprivation could potentially 
suggest some treatment strategies. 
To perform the study we required 
a relevant in vitro assay. In the midbrain 
cultures, the dopaminergic neurons 
constitute only a subpopulation of 
neurons. Moreover, our experiments often 
require transfection of the neurons and 
consequently recognition of transfected 
dopaminergic neurons among non-
transfected and non-dopaminergic neurons 
to monitor their survival/death after 
neurotrophic factor deprivation. Such an 
assay was not available, so we had to fi rst 
develop it.
We cultured the neurons with GDNF 
on a standard small area of the culture 
dish that enables us to count all of the 
neurons, and co-transfected the cultures 
with the plasmid of interest, together 
with the reporter plasmid for eGFP using 
the calcium phosphate co-precipitation 
technique. Such an approach enabled 
the visualization of the same transfected 
neurons before and after GDNF deprivation, 
allowing us to calculate the percentage of 
surviving transfected neurons for each 
dish (experimental point) individually. 
Because both dopaminergic neurons and 
non-dopaminergic neurons get transfected 
in the mixed culture, we stained the culture 
with antibodies to TH, the specifi c marker 
for dopaminergic neurons at the end of 
the experiment, and counted the number 
of neurons positive for both eGFP and 
TH. This number was normalized to the 
number of initially transfected neurons 
counted from the same dish. We also 
counted the number of transfected non-
dopaminergic (TH-negative) neurons that 
did not die due to GDNF-deprivation, and 
subtracted this number from the initial and 
fi nal experimental counts. Thereby we got 
the relevant estimation of the fraction of 
transfected dopaminergic neurons that 
survived after the deprivation of GDNF. 
4.4. GDNF- or BDNF-deprived 
dopaminergic neurons die via a non-
mitochondrial pathway which requires 
activation of death receptors and 
caspases (IV)
Having a reliable assay, we then studied 
the death pathways activated in the 
dopaminergic neurons by deprivation of 
GDNF. For comparison we chose another 
neurotrophic factor, BDNF that also 
promotes survival of the dopaminergic 
neurons, but by a different receptor, TrkB 
(a homologue of NGF receptor TrkA, 
chosen for the comparison in the study of 
sympathetic neurons).
We cultured dopaminergic neurons 
with GDNF or BDNF for 5 days in vitro. 
Deprivation of the factors induced death 
in about half of the dopaminergic neurons 
within three days. To study the involvement 
of the mitochondrial death pathway, 
we stained GDNF- or BDNF-deprived 
cultures with antibodies to cytochrome c 
and TH. In the vast majority of GDNF- 
or BDNF-deprived TH-positive neurons, 
cytochrome c localization was punctate, 
the same mitochondrial localization as 
in factor-maintained neurons, showing 
that it is not released to the cytosol. We 
overexpressed Ku70 in GDNF- or BDNF-
deprived neurons to check the role of Bax 
in the death pathway. Ku70 had no effect 
on the death of these factor-deprived 
neurons, showing that Bax is not required 
for this process. Immunostaining of 
GDNF- or BDNF-deprived neurons with 
Bax antibody also revealed its diffuse, 
cytosolic localization. Overexpressed anti-
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apoptotic Bcl-2 family member Bcl-xL did 
not block the death of GDNF- and BDNF-
deprived neurons. Thus, we conclude 
that the mitochondrial pathway is not 
activated in GDNF- or BDNF-deprived 
dopaminergic neurons.
Since caspase inhibitor BAF can 
completely block the death of GDNF- and 
BDNF- deprived dopaminergic neurons, 
it was clear that caspases are absolutely 
required. We then checked which caspases 
are involved. We overexpressed dominant-
negative mutants of caspase-2, -3, -7, 
and -9 in the GDNF- or BDNF-deprived 
neurons. Blocking of caspase-3, -7, and 
-9 signifi cantly protected the neurons 
from death induced by GDNF- or BDNF-
deprivation, whereas blocking caspase-
2 had no statistically signifi cant effect. 
Thus, different caspases are activated 
in the GDNF-deprived sympathetic and 
dopaminergic neurons. 
To check the involvement of another 
classical apoptotic pathway, the death 
receptor pathway, we fi rst checked the 
Fas receptor and FasL expression in our 
cultures. By RT-PCR and immunostaining, 
we clearly verifi ed the expression of both 
Fas receptor and FasL in the dopaminergic 
neurons. We then transfected the neurons 
with dominantly blocking mutants of 
caspase-8 and FADD, both constructs 
blocked the death of GDNF- and BDNF-
deprived dopaminergic neurons, showing 
that the death receptor pathway was 
activated. To get further evidence for this 
claim we applied agonistic and antagonistic 
research tools used in other studies of 
Fas. Antagonistic Fas-Fc, a chimaeric 
decoy containing the extracellular domain 
of Fas, shown to prevent interaction of 
Fas and FasL in motoneurons (Raoul 
et al., 2002), signifi cantly blocked both 
GDNF- and BDNF- deprivation induced 
neuronal death. Furthermore, ligation of 
Fas by agonistic Jo2 anti-Fas antibody 
killed GDNF- and BDNF-maintained 
neurons. Thus, in contrast to GDNF (and 
NGF) -deprived sympathetic neurons 
(study I), the Fas-like death receptors are 
activated in GDNF- and BDNF-removed 
dopaminergic neurons. 
Our immunostaining study shows 
that both Fas and FasL are constitutively 
expressed in the midbrain cultures. This 
differs from the immune system where 
FasL is induced on the killer cells only 
upon stimulation, to avoid unwanted 
killing of the cells (Ashkenazi and Dixit, 
1998). We hypothesized the existence 
of a constitutive inhibitor of Fas in the 
dopaminergic neurons that would keep 
Fas apoptotically inactive in the normal 
situation, but could be removed upon 
neurotrophic factor deprivation. One such 
candidate is the long form of Fas apoptosis 
inhibitory molecule FAIML, which has 
been shown to associate with Fas and 
prevent its apoptotic activity specifi cally 
in the neurons (Segura et al., 2007). 
By immunoblot, we demonstrated its 
expression in our mixed neuronal culture. 
Endogenous FAIML was coprecipitated 
with transfected Fas from the GDNF- and 
BDNF-maintained cultures, suggesting 
physical association of these proteins. 
Overexpressed Fas signifi cantly killed 
GDNF- and BDNF- maintained neurons. In 
contrast, overexpressed FAIML signifi cantly 
blocked the death of GDNF- and BDNF-
deprived neurons, and this protection was 
abolished upon cotransfection with Fas. 
Thus, Fas and FAIML can functionally and 
physically interact with each other in the 
dopaminergic neurons. We were not able 
to check, however, whether FAIML could 
be degraded upon GDNF deprivation. It is 
also expressed in other, non-dopaminergic 
neurons that constitute the majority in 
our cultures and overwhelm the possible 
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changes in the dopaminergic neurons in 
our tests.
We conclude that GDNF- and BDNF-
deprived dopaminergic neurons die via 
a non-mitochondrial pathway, which 
activates death receptors and caspases. 
Withdrawal of the same factor GDNF 
triggers different death pathways in the 
sympathetic and dopaminergic neurons, 
whereas withdrawal of different factors 
(GDNF or BDNF) trigger the same death 
machinery in the dopaminergic neurons.
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5. DISCUSSION
Neurons from both the peripheral and 
central nervous systems need trophic 
support from different sources for survival 
at specifi c development stages. The same 
type of neurons can be responsive to 
several factors at different times during 
development. For example, neurotrophins 
can promote the survival of largely 
separate sub-populations of somatic 
embryonic sensory neurons both in vivo 
and in vitro (Levi-Montalcini, 1966; 
Levi-Montalcini, 1987a; Smeyne et al., 
1994; Ockel et al., 1996b; Liebl et al., 
1997; Ockel et al., 1996a; Maisonpierre 
et al., 1990). Lack of this support leads 
to ontogenetic death of these neurons 
(Oppenheim, 1991, Huang and Reichardt, 
2001). Apoptotic death of neurons, even 
the same type of neurons, can be evoked 
by different initiating events. Multiple 
pathways of apoptotic death may exist in 
cells. It is still poorly understood how and 
why deprivation of different factors from 
the same neuron could sometimes trigger 
different pathways. 
The NGF-dependent sympathetic 
neurons have been extensively used to 
study the mechanism of neuronal PCD. 
Removal of NGF from these neurons 
induces cell death via the well-known 
mitochondrial pathway: releasing of 
cytochrome c (Deshmukh and Johnson, 
1998; Martinou, 1999; Neame et al., 1998; 
Martinou et al., 1999), Bax translocation 
(Deckwerth et al., 1996; Putcha et al., 
1999), activation of caspase-9 and -3 
(Deshmukh et al., 2000; Deshmukh et al., 
2002), and inhibition of the death by Bcl-
xL (Gonzalez-Garcia et al., 1995). The 
death pathways activated by withdrawal 
of other neurotrophic factors have been 
much less explored. 
We compared the death machineries 
triggered in the same neuron (sympathetic 
neurons in paper I; DRG neurons in paper 
II; dopaminergic neurons in paper IV) by 
removal of two different factors (NGF or 
GDNF in paper I; NGF or NT-3 in paper 
II; GDNF or BDNF in paper IV). To our 
surprise, we found that the death pathways 
differed considerably in different cell types 
and after deprivation of different trophic 
factors.  
Compared to NGF-deprived 
sympathetic neurons, removal of GDNF 
from these neurons activated a novel death 
pathway: cytochrome c was not released; 
Bax and Bcl-xL were not involved; 
caspase-3 and -9 were not activated and 
the ultrastructure of mitochondria was 
unchanged. The way deprivation of SCG 
neurons of two different neurotrophic 
factors triggers the two different death 
programs is currently unknown.  Loss 
of survival signals, like trophic support, 
passively releases the death program, but 
active death triggering may also occur. 
Recently, the concept of dependence 
receptors has been developed. Receptors 
of this family transmit positive signals of 
survival, proliferation, differentiation, or 
migration in the presence of ligand, but 
actively trigger apoptosis in the absence 
of ligand via a novel mechanism that 
involves receptor cleavage (Bredesen 
et al., 2004). Ret was suggested to be a 
dependence receptor, since unligated Ret 
can be cleaved by caspase-3 and generate 
an apoptotic fragment (dependence 
domain) that can trigger apoptosis in some 
cell lines (Bordeaux et al., 2000; Canibano 
et al., 2007). Thus, one possibility is that in 
the SCG neurons, the dependence domain 
of deliganded Ret itself actively triggers 
death via a non-mitochondrial pathway, 
whereas deliganded TrkA that is not a 
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dependence receptor (II), only passively 
releases the mitochondrial apoptotic 
machinery. Such triggering of a non-
classical death pathway has been described 
for the dependence domain of DCC (Forcet 
et al., 2001). It has been shown, however, 
that Ret does not act as a dependence 
receptor in enteric neurons in vivo (Uesaka 
et al., 2008). Overexpression of Ret, or 
the apoptotic fragment of Ret, in both 
NGF- and GDNF-dependent sympathetic 
neurons did not induce death in our hands 
(unpublished data), suggesting that the 
active death stimulus from unbound Ret is 
not generated in the sympathetic neurons. 
The mechanisms by which deliganded 
Ret and TrkA activate different death 
programs in cultured sympathetic neurons 
require further studies. We speculate that 
maintaining the neurons with GDNF for 
5-6 days differentiates those that could, 
among other things, include expression 
of a separate death machinery (e.g. the 
machinery for caspase-2 activation) and/
or render the mitochondrial pathway 
nonfunctional. Whether and when such a 
pathway is activated in vivo is not known. 
As the GDNF-responsive SCG neurons 
are most probably also under the infl uence 
of NGF, it is tempting to speculate that 
local removal of GDNF could give 
an opportunity to remove them via an 
alternative pathway, even in the presence 
of NGF.
We found, however, that another 
tyrosine kinase receptor-TrkC functions 
as a dependence receptor in DRG neurons. 
Because the death of the cells, induced 
by NT-3 removal, critically depends on 
the release of a pro-apoptotic dependence 
domain from TrkC. This pro-apoptotic 
function is not caused by abnormal 
autoactivation of TrkC, because a kinase-
dead mutant still displays a similar pro-
apoptotic activity. In contrast, the caspase 
cleavage sites were not found at the 
corresponding positions in TrkA or TrkB 
and the intracellular domains of TrkA 
and TrkB can not be cleaved by caspase-
3. It suggested that even closely related 
receptors like TrkA, TrkB, and TrkC can 
act differently regarding cell survival/
cell death.  We propose that TrkA and 
TrkB can induce only positive signaling 
when liganded, but remain passive when 
deliganded leading to cessation of the 
survival signaling. Liganded TrkC also 
induces positive signaling that ceases 
upon ligand removal. Deliganded TrkC, 
however, also triggers an active negative 
(apoptotic) signaling. Thus, TrkC actively 
controls both survival and death depending 
on its ligation status and is therefore a 
dependence receptor. Analyses of NT-3−/− 
and TrkC mutant mice suggests that NT-
3 is involved in multiple aspects of early 
sensory neuron development (Klein et al., 
1994; Tessarollo et al., 1994; Tessarollo et 
al., 1997), and overexpression of NT-3 in 
developing neurons increases the number 
of DRG neurons in vivo (Ringstedt et al., 
1997). Data from knockouts revealed that 
the same amount of noxiceptive sensory 
neurons are lost at birth in both TrkA and 
NGF null mice (Crowley et al., 1994). 
Similarly, inactivation of either the TrkB or 
BDNF gene in mice results in an equivalent 
loss of the respective mechanoceptive 
neurons (Minichiello et al., 1995; Ernfors 
et al., 1994a). Neuronal counts in sensory 
ganglia of the TrkC mutant mice present a 
30% loss, whereas more severe losses of 
about 70% were found in NT-3 null mutant 
mice (Ernfors et al., 1994b; Tessarollo et 
al., 1994; Tessarollo et al., 1997; Klein 
et al., 1994). One explanation for this 
discrepancy could be that NT-3 most 
effectively activates the TrkC receptor 
tyrosine kinase, but it can also signal using 
the TrkA and TrkB receptor (White et al., 
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1996). A critical role for NT-3 signaling 
via TrkA is well-established in the 
sympathetic neuron development (Francis 
et al., 1999; Kuruvilla et al., 2004). TrkC 
as a dependence receptor, however, could 
be an alternative explanation. Indeed, 
the neuronal death of TrkC mutant mice 
could be the result of only the loss of 
the positive signaling kinase activity of 
TrkC, whereas neuronal death observed 
in NT-3 knockouts could be the result of 
both the loss of the positive signaling and 
the pro-apoptotic activity of deliganded 
TrkC. Further studies are needed to 
investigate this hypothesis. In particular, 
it would support the dependence receptor 
hypothesis if the neuronal losses in mice 
double-defi cient for NT-3 and TrkC would 
be less severe than in mice defi cient for 
only NT-3. 
We have shown that in sympathetic 
neurons, GDNF-deprived neurons 
die via a caspase-dependent, but non-
mitochondrial, death pathway. To check 
whether this pathway is a specifi c feature 
of GDNF deprivation (deligation of 
Ret) we analyzed another population 
of neurons, the dopaminergic neurons, 
which also depend on GDNF signaling 
via GFRα1/Ret for survival in vitro. The 
survival of dopaminergic neurons is also 
promoted by BDNF, via the receptor 
TrkB. We found that GDNF deprivation 
activates a different death program in 
the dopaminergic neurons than in the 
sympathetic neurons. The death receptors 
and caspases, but not the mitochondria, 
were activated. Furthermore, a completely 
different set of caspases was activated in 
the GDNF-deprived dopaminergic neurons 
compared to the sympathetic neurons. 
One unexpected fi nding was that 
although cytochrome c was not released 
into the cytosol, caspase-9 was still 
activated in GDNF- and BDNF-deprived 
dopaminergic neurons. In the classical 
mitochondrial death pathway, caspase-9 is 
activated at the apoptosome that forms in 
the cytosol when cytochrome c and dATP 
bind the monomeric scaffold protein Apaf-
1. Recruitment of pro-caspase-9 to the 
apoptosome activates it by dimerization 
(Pop et al., 2006; Logue and Martin, 
2008; Boatright and Salvesen, 2003) and 
it is also cleaved to enhance its catalytic 
activity (Boatright and Salvesen, 2003; 
Bao and Shi, 2007; Logue and Martin, 
2008). How caspase-9 is activated in our 
system without apoptosome is not clear. 
We propose that it is activated by caspase-
8, previously activated at the DISC formed 
by the death receptor Fas. Consistent with 
this idea, McDonnell and colleagues have 
shown that caspase-9 can be cleaved and 
activated by active caspase-8 in response 
to TNF receptor activation in murine cells 
(McDonnell et al., 2003). Similarly, in 
murine embryonic fi broblasts, caspase-
8 cleaves and activates caspase-9 
independent of apoptosome in response 
to TNF (Gyrd-Hansen et al., 2006).  Thus, 
in dopaminergic neurons, caspase-9 may 
also be cleaved and activated by caspase-
8. We could not visualize the cleavage 
fragment of caspases due to the small 
mount of material, plus immunostaining 
of the neurons with antibodies to activate 
caspase also failed in our hands. Thus, 
how caspase-9 is activated requires further 
studies. 
To our surprise, death receptors, in 
particular Fas were activated in GDNF- and 
BDNF- deprived dopaminergic neurons. 
Inhibition of caspase-8 or FADD, but also 
overexpression of Fas inhibitor FAIML 
blocked death. Usage of Fas agonists 
and antagonists also confi rmed this 
phenomenon. The biology of Fas and FasL 
have mainly been studied in the immune 
system, but there is increasing evidence of 
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their involvement in the nervous system 
(Raoul et al., 2006; Raoul et al., 1999), 
Although, Fas-mediated signaling is not 
involved in trophic factor deprivation-
induced apoptosis of sympathetic neurons 
(Putcha et al., 2002). Fas and FasL, however, 
are broadly expressed in the nervous 
system. Moreover, there is an increasing 
body of evidence that Fas and other 
members of the TNFR family can trigger 
cellular responses other than apoptosis, 
such as infl ammatory responses, cell 
growth, differentiation, and proliferation 
(Magnusson and Vaux, 1999; Beyaert et 
al., 2002; Wallach et al., 1999; Peter et al., 
2007). Our study favors the model that Fas 
performs other, non-apoptotic functions in 
the healthy nervous system, whereas its 
death-inducing potential is only released in 
the apoptotic situation, such as deprivation 
of neurotrophic factors. Indeed, we found 
FasL constitutively expressed in the 
midbrain cultures, suggesting a constitutive 
activation of Fas. Avoiding unwanted 
apoptosis requires an inhibitor that could 
normally block Fas, but it is removed in 
the apoptotic situation. Recently a neuron-
specifi c inhibitory protein FAIML was 
described as interacting with Fas, and 
blocking the apoptotic activity of Fas in 
neurons (Segura et al., 2007). We confi rmed 
the interaction of FAIML and Fas in our 
dopaminergic neuron model. In healthy 
dopaminergic neurons, Fas could have 
other functions than apoptosis, because its 
apoptotic function is blocked by FAIML. 
Whereas when an apoptotic stimulus, 
such as neurotrophic factor deprivation 
is received, FAIML can be removed from 
Fas and induce cell death. We were, 
however, unable to check whether FAIML 
is degraded by GDNF deprivation due to 
technical limitations of the model. 
We found that unbouded Ret triggers 
different death pathways in sympathetic 
and dopaminergic neurons, whereas the 
same pathways were activated in the 
dopaminergic neurons by deligation of 
Ret and TrkB. We expected different death 
pathways triggered by GDNF and BDNF 
deprivation, because that was the case in 
sympathetic neurons deprived of NGF or 
GDNF (paper I). But in both cases, the 
dopaminergic neurons died by the same 
program, at least as judged by the proteins 
whose involvement we tested. Thus, 
which death pathway gets activated is 
determined by the type of the neurons, not 
by the type of deprived factor/deliganded 
receptor. We conclude that dopaminergic 
neurons responded differently to GDNF 
deprivation than sympathetic neurons, but 
in the same way as BDNF deprivation. It 
seems that upon removal of the trophic 
factor, neurons have their own neuronal 
type-specifi c way to die. Still, even in 
the same neuron, different death stimuli 
can trigger different death pathways. For 
example, dopaminergic neurons treated 
with MPP+ or 6-OHDA can activate 
different death pathways that are still 
different from factor deprivation-induced 
death program (Choi et al., 1999). It is 
becoming increasingly clear that a cell 
has more than one death pathway, which 
are stimulus-dependent, but different cell 
types have their own “main” pathway. The 
classic mitochondrial pathway is clearly 
important, but not the only one. 
It remains to be studied whether the 
dopaminergic neurons die ontogenetically 
in vivo via that pathway. Moreover, the role 
of endogenous GDNF in the ontogenetic 
death is controversial. The studies by Burke 
and coworkers demonstrated that GDNF 
can regulate the death of dopaminergic 
neurons in vivo (Oo et al., 2003). They 
also showed that dopaminergic neurons in 
the SN undergo ontogenetic cell death at 
the peak of postnatal days 2 and 14 (Oo 
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and Burke, 1997).  Injection of GDNF into 
the striatum during the biphasic period of 
ontogenetic cell death inhibited apoptosis 
of dopaminergic neurons, although 
only during the fi rst period of cell death 
(Kholodilov et al., 2004; Burke, 2004). 
Thus, the experiments with acute in vivo 
manipulations suggest that GDNF is a 
bona fi de target-derived neurotrophic 
factor for the dopaminergic neurons. On 
the other hand, the data from transgenic 
mice suggests different conclusions. The 
knockouts of GDNF or its receptors are not 
informative in that respect, since all these 
mice die at birth, i.e. before the ontogenetic 
death period of the dopaminergic neurons 
(Baloh et al., 2000; Pichel et al., 1996; 
Cacalano et al., 1998; Enomoto et al., 1998; 
Taraviras et al., 1999; Krieglstein, 2004). 
Two different lines of Ret conditional 
knockout mice, surviving to adulthood, 
however, did not reveal changes in the 
number of dopaminergic neurons at the 
time of ontogenetic death. Rather, these 
neurons were affected in the adult animals 
(Jain et al., 2006; Kramer et al., 2007). 
Thus, the role of GDNF and Ret in the 
developmental death of dopaminergic 
neurons requires further studies. GDNF, 
however, is still the most probable survival 
factor for these neurons in vivo (Pascual et 
al, 2008; Andressoo and Saarma, 2008).
Our data showing activation of 
Fas by GDNF deprivation suggests that 
suppression of death receptors could be 
one mechanism by which GDNF prevents 
the degeneration of dopaminergic neurons 
in Parkinson’s patients. Indeed, although 
the activation of death receptors in the 
dopaminergic neurons during ontogenetic 
death in vivo is not yet described, they 
are shown to be activated in Parkinson’s 
disease (Hartmann et al., 2002). Human 
postmortem studies have revealed an 
increased number of dopaminergic 
neurons that displayed caspase-8 activation 
(Hartmann et al., 2001), and a decrease 
in FADD-immunoreactive dopaminergic 
neurons in patients with Parkinson’s 
disease (Hartmann et al., 2002). It is not 
certain that the shortage of GDNF has 
any role in the etiology of Parkinson’s 
disease, but the potent neuroprotective 
ability of GDNF together with our results 
strongly suggest that GDNF acts, at least 
partially, via inhibition of death receptors 
in the affected dopaminergic neurons. It is 
tempting to speculate that the development 
of small molecule therapeutic Fas 
antagonistic mimetics could prevent death 
receptor activation, targeting Fas, FasL, 
FAIML, other components of DISC, or other 
death signaling components and prevent 
their activation, just as GDNF does. Such 
small molecules could be applied more 
conveniently than the recombinant protein 
factors. Currently only few examples of 
such mimetics exist (Hasegawa et al., 2004) 
and the consequences of their application 
in the brain are currently not known. For 
example, the death receptors like Fas 
are reported to be engaged to neurite 
outgrowth in DRG and hippocampal cells 
(Desbarats et al., 2003; Kajiwara et al., 
2004). Thus, such small molecules which 
can prevent the Fas activity, could also 
lead to neurite degeneration. Our results, 
however, encourage us to consider the 
death receptor pathway as a target for the 
treatment of neurodegenerative diseases.  
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6. CONCLUSIONS
1.  The neuronal death induced by removal of GDNF or NGF is considerably different. 
GDNF-deprived sympathetic neurons die via a novel non-mitochondrial, c-jun, and 
caspase-dependent pathway, whereas NGF-deprived sympathetic neurons die via 
classical mitochondrial death pathway.
2.  TrkC is a dependence receptor and the dependence receptor activity is necessary for 
the death of NT-3-deprived sensory neurons. NT-3 deprivation-induced cell death 
is not only due to the loss of survival signals, but also due to the active cell death 
stimulus triggered by unbound TrkC.
3.  We established a survival assay of transiently transfected dopaminergic neurons to 
analyze the apoptotic proteins in these neurons.
4.  GDNF-deprived dopaminergic neurons die via a non-mitochondrial pathway which 
involves the activation of death receptors and caspases. Withdrawal of different 
factors (GDNF or BDNF) triggers the same death machinery in the dopaminergic 
neurons.
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